:START_ID,:TYPE,:END_ID
http://example.org/fda/7521460749435599233,hasRecallReason,"Labeling: Label Mixup: DRONEDARONE HCL, Tablet, 400 mg may be potentially as the following drug:  METHYLERGONOVINE MALEATE, Tablet, 0.2 mg, NDC 43386014028, Pedigree: AD52778_40, EXP: 5/20/2014."
http://example.org/fda/3982123762646105362,hasRecallType,Class III
http://example.org/fda/808820976677340677,hasRecallType,Class II
http://example.org/fda/367732347997371290,hasRecallType,Class II
http://example.org/fda/4040241833474742646,hasRecallReason,"Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance."
http://example.org/fda/384081700434397511,hasRecallReason,Non-Sterility: Out of specification results for the sterility test for microbial contamination.
http://example.org/fda/2570782316828393775,hasRecallType,Class II
http://example.org/fda/5062196777165891174,hasRecallType,Class II
http://example.org/fda/3024017178754014875,hasRecallType,Class II
http://example.org/fda/4961691475717183597,hasRecallReason,cGMP deviations: Temperature abuse
http://example.org/fda/9014846806144910241,hasRecallType,Class II
http://example.org/fda/3683361109687816591,hasRecallType,Class II
http://example.org/fda/1356070627840597646,hasRecallType,Class II
http://example.org/fda/8273643561775248295,hasRecallType,Class II
http://example.org/fda/2018241912162728491,hasRecallType,Class II
http://example.org/fda/5943648916631051106,hasRecallReason,Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.
http://example.org/fda/8579179636244859683,hasRecallType,Class III
http://example.org/fda/407320578040319787,hasRecallReason,Labeling Not Elsewhere Classified: Fresenius Kabi is taking this action due to an incorrect statement on the product insert for product codes 918610 and 918620 indicating that the stoppers do not contain natural rubber latex.  The tray label for these two product codes and the vial label for product code 918620 also incorrectly state that the stoppers do not contain latex.  The above listed product codes and batches being recalled have stoppers containing natural rubber latex.
http://example.org/fda/7773860314772784832,hasRecallType,Class II
http://example.org/fda/8079525963798729736,hasRecallType,Class II
http://example.org/fda/5081223102235582558,hasRecallType,Class II
http://example.org/fda/8281536037074342595,hasRecallType,Class II
http://example.org/fda/2411093456480000478,hasRecallReason,Failed Moisture Limits: Out of specification for water content
http://example.org/fda/2032493010192080440,hasRecallReason,"Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes."
http://example.org/fda/3895082885813004196,hasRecallType,Class II
http://example.org/fda/7417088806130813289,hasRecallType,Class II
http://example.org/fda/40524938456871169,hasRecallType,Class II
http://example.org/fda/1753287250592091855,hasRecallReason,Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
http://example.org/fda/7189870077174860209,hasRecallType,Class II
http://example.org/fda/6477651893248341312,hasRecallType,Class II
http://example.org/fda/3882588970850523105,hasRecallType,Class III
http://example.org/fda/1490183212728441718,hasRecallType,Class II
http://example.org/fda/4405922135090031232,hasRecallType,Class II
http://example.org/fda/5807110359766546636,hasRecallType,Class II
http://example.org/fda/7188674135987218275,hasRecallType,Class II
http://example.org/fda/6587240819303789574,hasRecallReason,Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
http://example.org/fda/7735778202937274747,hasRecallType,Class II
http://example.org/fda/1725727208492952978,hasRecallReason,Microbial contamination
http://example.org/fda/3504142143160994634,hasRecallType,Class II
http://example.org/fda/8404214759353557102,hasRecallReason,Lack of Assurance of Sterility: product sterility cannot be guaranteed.
http://example.org/fda/6067345253356013953,hasRecallReason,Failed Impurities/Degradation Specifications: out of specification test results for impurities during stability testing.
http://example.org/fda/4744804525383498128,hasRecallReason,"Lack of processing controls: Isomeric Pharmacy Solution, LLC is recalling Betamethasone Acetate / Betamethasone Sodium Phosphate 7 mg/mL INJ SUSP because of the potential of drug clumps in the vial of the sterile drug product and larger particle sizes."
http://example.org/fda/732811141567878642,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/8066816553310098258,hasRecallType,Class II
http://example.org/fda/6404191336835230191,hasRecallReason,"Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled."
http://example.org/fda/5543349536102650131,hasRecallType,Class II
http://example.org/fda/5676131448971395090,hasRecallType,Class II
http://example.org/fda/3543994620605935726,hasRecallType,Class II
http://example.org/fda/8667424537466132224,hasRecallType,Class II
http://example.org/fda/8281536037074342595,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/6916240935412328329,hasRecallReason,Presence of Foreign Tablets/Capsules: Potential of Pravastatin tablet fragments in bottles of Valacyclovir 1 gm Tablets.
http://example.org/fda/1707404593015143996,hasRecallType,Class II
http://example.org/fda/4391837238336027994,hasRecallReason,CGMP Deviations
http://example.org/fda/5405211768256732780,hasRecallType,Class II
http://example.org/fda/524001158104578457,hasRecallReason,Lack of sterility assurance.
http://example.org/fda/6068837586859108846,hasRecallType,Class II
http://example.org/fda/7893163290718960111,hasRecallType,Class II
http://example.org/fda/2415290094488947825,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/7057521967548770484,hasRecallType,Class II
http://example.org/fda/1996045866837604011,hasRecallReason,CGMP Deviations:
http://example.org/fda/901679399558518357,hasRecallReason,Lack of Processing Controls
http://example.org/fda/6726906532897148136,hasRecallType,Class III
http://example.org/fda/8569436652345104574,hasRecallType,Class II
http://example.org/fda/5273245882125357156,hasRecallType,Class II
http://example.org/fda/822843178695061180,hasRecallType,Class II
http://example.org/fda/5015203132137530886,hasRecallType,Class II
http://example.org/fda/1492905594506216748,hasRecallType,Class II
http://example.org/fda/3387603055611786318,hasRecallType,Class II
http://example.org/fda/3051435568889263899,hasRecallType,Class II
http://example.org/fda/218418596035146660,hasRecallType,Class II
http://example.org/fda/5207682165290960185,hasRecallType,Class II
http://example.org/fda/8921121887376527129,hasRecallReason,CGMP Deviations: Intermittent exposure to temperature excursion during storage.
http://example.org/fda/5273245882125357156,hasRecallReason,Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
http://example.org/fda/4685663675194709031,hasRecallReason,Microbial Contamination of Non-Sterile Product
http://example.org/fda/6561490618600331028,hasRecallType,Class I
http://example.org/fda/7844786567003378540,hasRecallType,Class II
http://example.org/fda/3666104987526979386,hasRecallReason,Product Lacks Stability: Out-of-specification (OOS) results were observed for assay and description in retain samples.
http://example.org/fda/4196377834157244226,hasRecallReason,"Marketed without an approved NDA/ANDA: INK-EEZE Tattoo Numbing Spray contains 5% Lidocaine and is being marketed without an approved NDA/ANDA. Lidocaine 5% is an ingredient in many FDA approved products, making Ink-Eeze an unapproved new drug."
http://example.org/fda/5703919552904791628,hasRecallReason,The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
http://example.org/fda/774272886333321849,hasRecallReason,The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
http://example.org/fda/5861470992137626602,hasRecallType,Class II
http://example.org/fda/2488446281356045331,hasRecallType,Class II
http://example.org/fda/1092442564719582905,hasRecallType,Class III
http://example.org/fda/1519005063430050576,hasRecallReason,"Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance."
http://example.org/fda/1037904823850250812,hasRecallReason,"Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall."
http://example.org/fda/1245406076056372403,hasRecallType,Class II
http://example.org/fda/2912928930397201981,hasRecallType,Class II
http://example.org/fda/3074593630675410906,hasRecallReason,Superpotent Drug: Out Of Specification (OOS) result for Assay.
http://example.org/fda/5101058828775077661,hasRecallReason,Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
http://example.org/fda/3308938622265396435,hasRecallType,Class II
http://example.org/fda/3895082885813004196,hasRecallReason,Superpotent Drug: Failure of assay specifications in the capsule.
http://example.org/fda/2799581312305715741,hasRecallType,Class II
http://example.org/fda/5844514905704261192,hasRecallReason,Non-Sterility
http://example.org/fda/3959948659798033064,hasRecallReason,Presence of Particulate Matter: Confirmed customer compliants of finding an insect floating in the primary container of each product.
http://example.org/fda/5979752129384826765,hasRecallReason,Subpotent Drug - Out of specification (OOS) result obtained during monitoring stability study for Assay. Results below specification.
http://example.org/fda/506949931979825049,hasRecallType,Class II
http://example.org/fda/4845119076040711316,hasRecallReason,Presence of Particulate Matter: Customer complaint for an insect found free floating inside a single bag for each lot recalled.
http://example.org/fda/3916088784823844193,hasRecallReason,CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level
http://example.org/fda/5802790398249100682,hasRecallReason,Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
http://example.org/fda/5297499532472708739,hasRecallReason,Labelling: Missing label.
http://example.org/fda/3168254570326074609,hasRecallReason,CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.
http://example.org/fda/5089471053606457807,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/8724357199806671045,hasRecallReason,Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
http://example.org/fda/1971520662788227984,hasRecallReason,cGMP deviations: Temperature abuse
http://example.org/fda/2323567000396722020,hasRecallReason,Subpotent Drug: Out of specification result during stability study in Pramipexole Dihydrochloride Tablets 0.125 mg
http://example.org/fda/1112394949398489627,hasRecallType,Class II
http://example.org/fda/8656745747920022999,hasRecallReason,Lack of assurance of sterility: Lack of validation data for sanitization cycles
http://example.org/fda/86570348399702649,hasRecallType,Class II
http://example.org/fda/40524938456871169,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/9000806366982265534,hasRecallType,Class II
http://example.org/fda/255089739141511114,hasRecallType,Class II
http://example.org/fda/7874968880731509576,hasRecallType,Class I
http://example.org/fda/8978848376465809181,hasRecallType,Class II
http://example.org/fda/110952495759581795,hasRecallReason,Lack of Processing Controls
http://example.org/fda/5844514905704261192,hasRecallType,Class I
http://example.org/fda/3410941493983630141,hasRecallType,Class II
http://example.org/fda/4374321441451481748,hasRecallType,Class II
http://example.org/fda/8574929738884873953,hasRecallReason,"Microbial contamination of non-sterile products: product was found to contain mold, identified as Rhinocladiella similis."
http://example.org/fda/6591789956895921793,hasRecallType,Class I
http://example.org/fda/666342373472663903,hasRecallType,Class I
http://example.org/fda/3189993510889945638,hasRecallReason,The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
http://example.org/fda/3562280194981168888,hasRecallType,Class II
http://example.org/fda/2489972811354781569,hasRecallType,Class II
http://example.org/fda/7162405059949436568,hasRecallReason,Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
http://example.org/fda/4304938930654646794,hasRecallType,Class II
http://example.org/fda/1102023555993887318,hasRecallType,Class II
http://example.org/fda/7730603113499093964,hasRecallType,Class II
http://example.org/fda/1967115692604667357,hasRecallReason,Failed Content Uniformity Specifications
http://example.org/fda/3956845036673805252,hasRecallReason,Lack of sterility assurance
http://example.org/fda/3804091836034310382,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/5352190974573840176,hasRecallReason,CGMP Deviations: The Recall is due to the potential cross-contamination at the contract manufacturer (Ultra Tab Laboratories Inc.)
http://example.org/fda/5463466138591010752,hasRecallType,Class II
http://example.org/fda/58162533981096283,hasRecallType,Class II
http://example.org/fda/7234652138346976662,hasRecallType,Class II
http://example.org/fda/1871343900020037406,hasRecallReason,Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
http://example.org/fda/7976455593311045907,hasRecallType,Class II
http://example.org/fda/952546189032429376,hasRecallType,Class I
http://example.org/fda/1845224832799557540,hasRecallReason,Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
http://example.org/fda/7156902442997211577,hasRecallType,Class II
http://example.org/fda/2891884722807724437,hasRecallType,Class II
http://example.org/fda/5898399150036708394,hasRecallType,Class II
http://example.org/fda/302162446670228998,hasRecallType,Class II
http://example.org/fda/5902295057588828394,hasRecallType,Class II
http://example.org/fda/5010576779703374844,hasRecallReason,Microbial contamination
http://example.org/fda/9082652135188941729,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/3210753272608970587,hasRecallReason,Failed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).
http://example.org/fda/4733240281040240701,hasRecallType,Class II
http://example.org/fda/7524268140387362390,hasRecallType,Class II
http://example.org/fda/9200830486754588992,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/1897051234804533551,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/9082652135188941729,hasRecallType,Class II
http://example.org/fda/9184314195971090633,hasRecallReason,Subpotent Drug
http://example.org/fda/2956315119732606276,hasRecallReason,Lack of Assurance of Sterility: Product sterility cannot be guaranteed.
http://example.org/fda/5849567340444636255,hasRecallReason,"GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product."
http://example.org/fda/404888199326523759,hasRecallType,Class I
http://example.org/fda/6780050984056098725,hasRecallReason,CGMP deviations: Ibuprofen is being recalled in response to previous recall
http://example.org/fda/8548358030071668990,hasRecallType,Class II
http://example.org/fda/5690688283863114187,hasRecallType,Class II
http://example.org/fda/3724222658847333314,hasRecallType,Class II
http://example.org/fda/2779807000609768061,hasRecallReason,Defective Delivery System: One lot exceeded the mechanical peel specification
http://example.org/fda/3931842155487905604,hasRecallReason,"Incorrect/Undeclared Excipients: The inactive ingredients labeled on the product boxes and tubes are listed as ""mineral oil , petrolatum "". The inactive ingredients in the actual product are polyethylene glycol 400 , polyethylene glycol 4000."
http://example.org/fda/8071332324481361482,hasRecallReason,"Labeling: Incorrect or Missing Lot and/or Exp Date:The product labels contain a Two-Dimensional ( 2D ) barcode that, when scanned, reveals information specific to the batch of the labeled product, including Expiration Date.  The expiration date included within these 2D barcodes is incorrect and does not match the correct expiration date listed on the face of the label itself."
http://example.org/fda/8569436652345104574,hasRecallReason,The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
http://example.org/fda/398713013471504612,hasRecallReason,"Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this  compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes."
http://example.org/fda/4665228673232607514,hasRecallType,Class II
http://example.org/fda/3234473925676585424,hasRecallType,Class II
http://example.org/fda/651690536257417662,hasRecallReason,CGMP Deviations: product held outside appropriate storage temperature conditions.
http://example.org/fda/1341468551903622727,hasRecallType,Class III
http://example.org/fda/2273677172561869419,hasRecallReason,CGMP Deviations: Intermittent exposure to temperature excursion during storage.
http://example.org/fda/3801973635739011813,hasRecallType,Class II
http://example.org/fda/7151230533610376950,hasRecallType,Class II
http://example.org/fda/3601249222347075583,hasRecallReason,"Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Rohto Hydra, Rohto Relief and Rohto Cool eye drops, due to concerns related to the quality assurance of sterility controls."
http://example.org/fda/8435593086707952289,hasRecallType,Class II
http://example.org/fda/7465698963587542716,hasRecallReason,Lack of sterility assurance.
http://example.org/fda/1092442564719582905,hasRecallReason,Superpotent Drug: Out Of Specification (OOS) result for Assay.
http://example.org/fda/6889987536583532215,hasRecallReason,Lack of assurance of sterility.
http://example.org/fda/4440332540343096274,hasRecallType,Class II
http://example.org/fda/1313217515812686071,hasRecallReason,CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.
http://example.org/fda/1528684812105043862,hasRecallReason,CGMP Deviations: Firm went out of business and could no longer continue stability studies.
http://example.org/fda/718695925851371717,hasRecallReason,CGMP Deviations: Firm went out of business and could no longer continue stability studies.
http://example.org/fda/1443857192782330487,hasRecallReason,Failed dissolution specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out of specification result.
http://example.org/fda/655325061961036829,hasRecallType,Class II
http://example.org/fda/1974181984681623483,hasRecallType,Class II
http://example.org/fda/4040241833474742646,hasRecallType,Class II
http://example.org/fda/8174232672460765929,hasRecallType,Class II
http://example.org/fda/5332580006076973578,hasRecallType,Class II
http://example.org/fda/4245305720532755595,hasRecallType,Class III
http://example.org/fda/3387603055611786318,hasRecallReason,CGMP Deviations: Born Basic Anti Bac was found to be below the label claim for ethanol content and contained methanol. Other products were recalled because they were manufactured in the same facility as the product found to contain methanol.
http://example.org/fda/3450213514466554403,hasRecallType,Class II
http://example.org/fda/6126084707546764376,hasRecallType,Class II
http://example.org/fda/1832401432115232977,hasRecallType,Class II
http://example.org/fda/5397927486643087974,hasRecallType,Class II
http://example.org/fda/3102873805890494037,hasRecallType,Class II
http://example.org/fda/8189869196326965490,hasRecallReason,"Labeling: Label Mixup: SOTALOL HCL, Tablet, 80 mg may have potentially been mislabeled as one of the following drugs:  DILTIAZEM HCL, Tablet, 120 mg, NDC 00093032101, Pedigree: AD30197_1, EXP: 5/9/2014;  PROPRANOLOL HCL ER, Capsule, 60 mg, NDC 00228277811, Pedigree: AD54605_4, EXP: 5/20/2014."
http://example.org/fda/8098353610739422367,hasRecallType,Class II
http://example.org/fda/5127818400268238480,hasRecallType,Class II
http://example.org/fda/9106876328622668730,hasRecallReason,Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer
http://example.org/fda/7471073216436811476,hasRecallType,Class II
http://example.org/fda/4405402144467774050,hasRecallType,Class II
http://example.org/fda/6774284630670253980,hasRecallReason,Microbial contamination
http://example.org/fda/3674046587181268177,hasRecallReason,"CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 100 mg were manufactured using an unapproved material: API was incorrectly released for use in manufacturing."
http://example.org/fda/6298535418388525736,hasRecallType,Class II
http://example.org/fda/5605912935943993728,hasRecallType,Class II
http://example.org/fda/3056941766737402743,hasRecallType,Class II
http://example.org/fda/1234977498889291382,hasRecallType,Class II
http://example.org/fda/4665228673232607514,hasRecallReason,Lack of Processing Controls.
http://example.org/fda/5721101016892001380,hasRecallType,Class II
http://example.org/fda/2431059756439988228,hasRecallType,Class III
http://example.org/fda/5397927486643087974,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/4576116828039010355,hasRecallType,Class II
http://example.org/fda/5481585765602254140,hasRecallType,Class II
http://example.org/fda/6967552668902703089,hasRecallReason,Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.
http://example.org/fda/3489812868828694491,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/3056941766737402743,hasRecallReason,Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
http://example.org/fda/6615831894161208796,hasRecallType,Class II
http://example.org/fda/8311842944573328195,hasRecallType,Class II
http://example.org/fda/4589070736164723439,hasRecallReason,Lack of sterility assurance.
http://example.org/fda/6204813206019224221,hasRecallReason,"Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves."
http://example.org/fda/3203142304938622972,hasRecallReason,Labeling: Incorrect or Missing Package Insert: authorized generic product was packaged with the incorrect insert for the brand name product Clolar (clofarabine) injection.
http://example.org/fda/3659390904870772626,hasRecallType,Class I
http://example.org/fda/2659203345960568091,hasRecallReason,The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
http://example.org/fda/293723083197211011,hasRecallType,Class II
http://example.org/fda/5500308585260750163,hasRecallReason,Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
http://example.org/fda/5036334514835396096,hasRecallType,Class II
http://example.org/fda/7733637645331361270,hasRecallType,Class II
http://example.org/fda/4845119076040711316,hasRecallType,Class I
http://example.org/fda/3220566464553225985,hasRecallType,Class II
http://example.org/fda/8094415693636661494,hasRecallReason,Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.
http://example.org/fda/4963507298550423603,hasRecallReason,CGMP Deviations: recalling drug products following an FDA inspection.
http://example.org/fda/8006955713321384004,hasRecallType,Class II
http://example.org/fda/2593560516793204124,hasRecallType,Class II
http://example.org/fda/4828232917996212801,hasRecallReason,"cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected."
http://example.org/fda/6768837804852047112,hasRecallType,Class III
http://example.org/fda/9092921149638678407,hasRecallType,Class II
http://example.org/fda/1646071971136916371,hasRecallReason,The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
http://example.org/fda/4240272725379959,hasRecallType,Class III
http://example.org/fda/7337733855620927115,hasRecallReason,CGMP Deviations: Next Advanced Antibacterial Hand Sanitizer was found to be below the label claim for ethanol content and contained methanol. Other products were recalled because they were manufactured in the same facility as the product found to contain methanol.
http://example.org/fda/7188674135987218275,hasRecallReason,Lack of Assurance of Sterility: Bags have the potential to leak.
http://example.org/fda/4844153180812288449,hasRecallReason,Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
http://example.org/fda/4220185341973768704,hasRecallType,Class II
http://example.org/fda/8385887789433874617,hasRecallType,Class III
http://example.org/fda/880552124706594358,hasRecallReason,Lack of Assurance of Sterility: incomplete or missing data regarding production.
http://example.org/fda/8862034963755189664,hasRecallType,Class II
http://example.org/fda/6594291594566370481,hasRecallType,Class II
http://example.org/fda/2972075183889940338,hasRecallReason,"Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves."
http://example.org/fda/1827800446294855597,hasRecallReason,Labeling: Label Error on Declared Strength- Unopened bottles of Ropinirole USP 3 mg tablets was found to be incorrectly labeled as Ropinirole USP 4 mg tablets..
http://example.org/fda/870307617136949255,hasRecallReason,Failed Dissolution Specifications-out-of-specification (OOS) test results observed for dissolution at the 6 month long term time point.
http://example.org/fda/6632254654122552851,hasRecallReason,Failed Stability Specifications: The subject lots exhibited OOS results for Homogeneity test (Moderate separation).
http://example.org/fda/7194270257118630941,hasRecallReason,Discoloration: Expansion of an earlier recall due to the presence of dark brown discoloration on the edges of the tablets.
http://example.org/fda/4344357535919148593,hasRecallReason,Subpotent Drug: Out Of Specification results for assay at the stability time-point of 24 months.
http://example.org/fda/1740694425964999632,hasRecallReason,"Chemical Contamination: FDA analysis found the product to contain methanol, acetaldehyde, and acetal above the limits."
http://example.org/fda/1740694425964999632,hasRecallType,Class I
http://example.org/fda/3955711492672179027,hasRecallType,Class II
http://example.org/fda/6344935714792076254,hasRecallReason,Superpotent Drug: Confirmed customer complaint of a single unit dose blister cavity containing 2 OXYCODONE HCl 5 mg tablets.
http://example.org/fda/8021671372545143323,hasRecallReason,Lack of Processing Controls
http://example.org/fda/950430504400370474,hasRecallReason,Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
http://example.org/fda/4873357824879196798,hasRecallReason,Presence of particulate matter.one confirmed  customer report of particulate matter within two semi-rigid bottles identified prior to use
http://example.org/fda/216698950834597024,hasRecallReason,CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.
http://example.org/fda/1559866602416670158,hasRecallType,Class II
http://example.org/fda/2350899368413010206,hasRecallReason,Marketed Without An Approved NDA/ANDA: FDA analysis of this product found it to contain undeclared steroids and steroid-like substances making this an unapproved new drug.
http://example.org/fda/4804309526329761421,hasRecallReason,Marketed without an Approved NDA/ANDA; product was found to contain undeclared sibutramine & phenolphthalein
http://example.org/fda/7495054917327794968,hasRecallType,Class II
http://example.org/fda/3161334286730679621,hasRecallReason,"Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance."
http://example.org/fda/932893144448276626,hasRecallReason,cGMP violations noted during the firm's most recent inspection.
http://example.org/fda/8659539876560996281,hasRecallReason,Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
http://example.org/fda/1719221022662843765,hasRecallReason,Superpotent and Subpotent drugs
http://example.org/fda/3231271667348113452,hasRecallReason,CGMP Deviations:OOS result was observed in 1-Methyl-4-Nitroso Piperazine (MNP) impurity.
http://example.org/fda/5152088132319480937,hasRecallType,Class II
http://example.org/fda/5303975491330534363,hasRecallType,Class II
http://example.org/fda/3495195552292565427,hasRecallType,Class II
http://example.org/fda/4538705385324184281,hasRecallReason,Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
http://example.org/fda/1655000515399706742,hasRecallType,Class III
http://example.org/fda/1359675142966164878,hasRecallType,Class III
http://example.org/fda/3337889018660385238,hasRecallType,Class III
http://example.org/fda/7819120239039670232,hasRecallReason,Non-Sterility: Out of specification results for the sterility test for microbial contamination.
http://example.org/fda/1804800381222757155,hasRecallReason,Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
http://example.org/fda/1860176053121681754,hasRecallReason,Microbial Contamination of Non-Sterile Products; Selected lots of Badger Baby and Kids Sunscreen Lotion were recalled due to microbial contamination.
http://example.org/fda/4017699896438512588,hasRecallType,Class II
http://example.org/fda/3787001343421867089,hasRecallType,Class II
http://example.org/fda/1393979656638794139,hasRecallType,Class II
http://example.org/fda/190620534637121135,hasRecallType,Class II
http://example.org/fda/6752953146064825680,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/1707404593015143996,hasRecallReason,Subpotent Drug.
http://example.org/fda/6586354867033757226,hasRecallReason,Microbal Contamination of Non-Sterile Product; FDA analysis found  salmonella contamination
http://example.org/fda/5456037845297307013,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/6848513816747356216,hasRecallType,Class II
http://example.org/fda/3160872010014452108,hasRecallType,Class II
http://example.org/fda/8126651517536332120,hasRecallReason,Lack of Sterility Assurance.
http://example.org/fda/773622596342044557,hasRecallType,Class II
http://example.org/fda/7604283748251002757,hasRecallReason,Lack of Processing Controls
http://example.org/fda/6646779126803047045,hasRecallReason,Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
http://example.org/fda/6591725625998264168,hasRecallReason,Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.
http://example.org/fda/6070568976331964791,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/3210046755733514833,hasRecallType,Class II
http://example.org/fda/6658360316564555471,hasRecallReason,CGMP Deviations: Firm went out of business and could no longer continue stability studies.
http://example.org/fda/4345974743262200128,hasRecallReason,Microbial Contamination of Non-Sterile Products: Bioburden out of specification results for Morphine Sulfate API.
http://example.org/fda/8218485386282252009,hasRecallType,Class II
http://example.org/fda/1315141679511226287,hasRecallReason,Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
http://example.org/fda/2643107810326183982,hasRecallReason,Chemical Contamination: Product recalled due to an elevated level of a residual solvent impurity in the API that exceeds the Threshold of Toxicological Concern (TTC) calculation for the impurity.
http://example.org/fda/7002005065341049048,hasRecallReason,"This recall of LIPTRUZET is being initiated due to  packaging defects. Some of the outer laminate foil pouches allowed in air and moisture, which could potentially decrease the effectiveness or change the characteristics of the product."
http://example.org/fda/2093943912642850078,hasRecallType,Class II
http://example.org/fda/5690688283863114187,hasRecallReason,"Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit"
http://example.org/fda/1142813141352456533,hasRecallReason,CGMP Deviations: Intermittent exposure to temperature excursion during storage.
http://example.org/fda/7645717689731015436,hasRecallType,Class II
http://example.org/fda/6472191523837515629,hasRecallType,Class III
http://example.org/fda/3543994620605935726,hasRecallReason,"CGMP Deviations: finished product produced with active ingredients recalled by the manufacturer, King Bio Inc., due to water contamination issues that could potentially affect the quality of this product."
http://example.org/fda/5849567340444636255,hasRecallType,Class II
http://example.org/fda/6925059999631253681,hasRecallType,Class III
http://example.org/fda/7739252233620817028,hasRecallType,Class II
http://example.org/fda/1291252698137508810,hasRecallType,Class II
http://example.org/fda/380865023867704079,hasRecallReason,Failed Stability Specifications: Below specification result for buprenorphine release rate.
http://example.org/fda/2834377656840734409,hasRecallType,Class III
http://example.org/fda/1497608214591708034,hasRecallReason,Microbial Contamination of Non-Sterile Products
http://example.org/fda/5807110359766546636,hasRecallReason,"Labeling: Label Mixup: PERPHENAZINE, Tablet, 8 mg may have potentially been mislabeled as the following drug:  NIFEdipine, Capsule, 10 mg, NDC 59762100401, Pedigree: AD52778_55, EXP: 5/20/2014."
http://example.org/fda/5862004479291370542,hasRecallReason,Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
http://example.org/fda/3044548868984091977,hasRecallType,Class II
http://example.org/fda/6421046544370814463,hasRecallType,Class II
http://example.org/fda/1390928786270389761,hasRecallReason,Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile and the labeling is misleading in relation to sterility claims.
http://example.org/fda/1551966173709212992,hasRecallReason,Marketed without an Approved NDA/ANDA: products were found to contain undeclared sildenafil
http://example.org/fda/3684473515189917511,hasRecallType,Class II
http://example.org/fda/3538725621261110904,hasRecallType,Class II
http://example.org/fda/3309978395713298308,hasRecallReason,CGMP Deviations: Firm did not adequately investigate customer complaints.
http://example.org/fda/4391837238336027994,hasRecallType,Class II
http://example.org/fda/9207793780382177016,hasRecallReason,Lack of Assurance of Sterility.
http://example.org/fda/2587449852097695253,hasRecallType,Class II
http://example.org/fda/7994568319266834322,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/9014846806144910241,hasRecallReason,Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.
http://example.org/fda/5532118654308936721,hasRecallReason,CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
http://example.org/fda/7438527658399186670,hasRecallType,Class I
http://example.org/fda/7975416540368056534,hasRecallType,Class II
http://example.org/fda/5151907207797773605,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/221318596039464384,hasRecallReason,Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
http://example.org/fda/3553778648603917013,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/6121598793798201419,hasRecallType,Class II
http://example.org/fda/3562280194981168888,hasRecallReason,Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
http://example.org/fda/4557493502924079406,hasRecallReason,Microbial contamination
http://example.org/fda/4701698022059088733,hasRecallType,Class II
http://example.org/fda/3495195552292565427,hasRecallReason,Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.
http://example.org/fda/1314468477279680824,hasRecallType,Class II
http://example.org/fda/2290531880430569568,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/776057029063811243,hasRecallType,Class III
http://example.org/fda/1102543250002933575,hasRecallReason,Failed Impurities/Degradation Products: Out of specification levels of the impurity m-chlorobenzoic acid were observed.
http://example.org/fda/6355717142212364473,hasRecallType,Class II
http://example.org/fda/1860176053121681754,hasRecallType,Class II
http://example.org/fda/7810487455928626104,hasRecallType,Class III
http://example.org/fda/3355456004593439874,hasRecallReason,Out-of-specification test results obtained for identification testing based on HPTLC analysis.
http://example.org/fda/2858168771539071938,hasRecallReason,Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
http://example.org/fda/3975569883174408744,hasRecallType,Class II
http://example.org/fda/814128516062705004,hasRecallType,Class I
http://example.org/fda/1443472022932438261,hasRecallType,Class II
http://example.org/fda/6361442044189741034,hasRecallReason,CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
http://example.org/fda/5352190974573840176,hasRecallType,Class II
http://example.org/fda/1811674826730437845,hasRecallReason,CGMP Deviations: Intermittent exposure to temperature excursion during storage.
http://example.org/fda/2418288982795059167,hasRecallReason,"Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil."
http://example.org/fda/247127179553936082,hasRecallReason,Lack of sterility assurance
http://example.org/fda/1249042915159075060,hasRecallType,Class II
http://example.org/fda/2023096200388967778,hasRecallType,Class II
http://example.org/fda/5862004479291370542,hasRecallType,Class II
http://example.org/fda/7521460749435599233,hasRecallType,Class II
http://example.org/fda/5303975491330534363,hasRecallReason,Lack of Processing Control
http://example.org/fda/5907249398687717953,hasRecallType,Class I
http://example.org/fda/6457283958782729097,hasRecallReason,Marketed Without an Approved ANDA/NDA: presence of sibutramine
http://example.org/fda/2604408822254990765,hasRecallType,Class II
http://example.org/fda/6730607084477073492,hasRecallReason,CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.
http://example.org/fda/7150800101904890030,hasRecallType,Class III
http://example.org/fda/827186348346506484,hasRecallType,Class II
http://example.org/fda/1232659104039000094,hasRecallType,Class II
http://example.org/fda/4604401595944914403,hasRecallType,Class II
http://example.org/fda/4926878072023357117,hasRecallType,Class III
http://example.org/fda/7194270257118630941,hasRecallType,Class II
http://example.org/fda/3292010419214146011,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/3312214653122391137,hasRecallType,Class II
http://example.org/fda/6204783284194343752,hasRecallType,Class II
http://example.org/fda/7645717689731015436,hasRecallReason,"Labeling: Label Mixup: ACETAMINOPHEN, CHEW Tablet, 80 mg may have potentially been mislabeled as one of the following drugs:  BENAZEPRIL HCL, Tablet, 40 mg, NDC 65162075410, Pedigree: AD49423_1, EXP: 5/16/2014;  ASCORBIC ACID, Tablet, 250 mg, NDC 00904052260, Pedigree: W003101, EXP: 6/13/2014;  OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: AD30028_1, EXP: 5/8/2014;  TACROLIMUS,"
http://example.org/fda/8591485834352018879,hasRecallType,Class II
http://example.org/fda/3956845036673805252,hasRecallType,Class II
http://example.org/fda/2146820948363689970,hasRecallReason,Marketed without an Approved NDA/ANDA: The Beast contains undeclared sildenafil which was discovered through FDA analysis.
http://example.org/fda/4695809960034135553,hasRecallReason,Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
http://example.org/fda/8761053859546105293,hasRecallReason,CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.
http://example.org/fda/2861658757770858395,hasRecallReason,Lack of Assurance of Sterility: Potential leakage of bags.
http://example.org/fda/7805890844669741538,hasRecallReason,The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
http://example.org/fda/7767674099949636286,hasRecallType,Class II
http://example.org/fda/3128885682495370555,hasRecallType,Class II
http://example.org/fda/6065238165430783693,hasRecallType,Class II
http://example.org/fda/6591789956895921793,hasRecallReason,Marketed Without an Approved NDA/ANDA: Product labeled to contain methanol making it an unapproved new drug and contains methanol
http://example.org/fda/6085816991586163718,hasRecallType,Class II
http://example.org/fda/2523720119532731862,hasRecallReason,Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.
http://example.org/fda/7156902442997211577,hasRecallReason,Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
http://example.org/fda/6889987536583532215,hasRecallType,Class II
http://example.org/fda/848799193121106078,hasRecallReason,Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.
http://example.org/fda/4963507298550423603,hasRecallType,Class II
http://example.org/fda/8024893346869080467,hasRecallReason,Lack of assurance of sterility
http://example.org/fda/9011284475972501580,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/2956315119732606276,hasRecallType,Class II
http://example.org/fda/2721211413405153959,hasRecallReason,CGMP Deviations: products manufactured under conditions that could impact its product quality.
http://example.org/fda/5666669798667484646,hasRecallReason,CGMP Deviations: finished products were manufactured with poor quality water.
http://example.org/fda/544218057041155072,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/1776851647173176362,hasRecallReason,"Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 137 mcg may have potentially been mislabeled as the following drug:  ISONIAZID, Tablet, 300 mg, NDC 00555007102, Pedigree: AD60272_70, EXP: 5/22/2014."
http://example.org/fda/7366656642825551563,hasRecallReason,Subpotent Drug
http://example.org/fda/1490183212728441718,hasRecallReason,Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
http://example.org/fda/802353277516011323,hasRecallType,Class II
http://example.org/fda/439547629257852353,hasRecallReason,Lack of assurance of sterility
http://example.org/fda/7353425449120722133,hasRecallType,Class III
http://example.org/fda/8885753467179844788,hasRecallReason,"Labeling:Label Mixup; VITAMIN B COMPLEX WITH C/FOLIC ACID, Tablet may be potentially mislabeled as    LEVOTHYROXINE SODIUM, Tablet, 88 mcg, NDC 00378180701, Pedigree: AD73652_10, EXP: 5/30/2014;  HYOSCYAMINE SULFATE ER, Tablet, 0.375 mg, NDC 43199001401, Pedigree: W003576, EXP: 6/24/2014;  MELATONIN, Tablet, 3 mg, NDC 51991001406, Pedigree: AD70655_14, EXP: 5/28/2014;  MELATONIN, Tablet, 3 mg, NDC"
http://example.org/fda/5223673382965262546,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/6820071363974839316,hasRecallReason,Lack of Assurance of Sterility: Media fill with bacterial contamination
http://example.org/fda/5381334668396065514,hasRecallReason,Failed Dissolution Specifications: low test results at the 18 month time-point
http://example.org/fda/412761485132398469,hasRecallType,Class II
http://example.org/fda/6485991236421482748,hasRecallReason,CGMP Deviations: lack of adequate release testing.
http://example.org/fda/2417467768967105799,hasRecallType,Class II
http://example.org/fda/2971079734506505899,hasRecallReason,CGMP Deviations: Intermittent exposure to temperature excursion during storage.
http://example.org/fda/2457401731003850597,hasRecallType,Class II
http://example.org/fda/6142637192711171678,hasRecallReason,Presence of Foreign Substance
http://example.org/fda/4998519183063738309,hasRecallReason,"Subpotent drug: Two lots of Oxycodone and Acetaminophen Capsules, USP 5/500 mg are being recalled due to low out of specification (OOS) assay result obtained at expiry (24 months) for the oxycodone portion of the product."
http://example.org/fda/6135055023904337178,hasRecallReason,"Labeling: Label Mixup; OMEGA-3 FATTY ACID, Capsule, 1000 mg may be potentially mislabeled as    NORTRIPTYLINE HCL, Capsule, 50 mg, NDC 00093081201, Pedigree: AD21790_70, EXP: 5/1/2014."
http://example.org/fda/7132575828604244815,hasRecallType,Class II
http://example.org/fda/5063486099511788002,hasRecallType,Class III
http://example.org/fda/66360009186297031,hasRecallReason,Microbial contamination
http://example.org/fda/5786190066212685328,hasRecallType,Class II
http://example.org/fda/1045597733887960152,hasRecallReason,Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer bag and the overwrap
http://example.org/fda/678697884453403886,hasRecallType,Class I
http://example.org/fda/3446471927468073458,hasRecallType,Class II
http://example.org/fda/2488446281356045331,hasRecallReason,Lack of Assurance of Sterility; media fill failure at manufacturer
http://example.org/fda/2248661098883559703,hasRecallType,Class II
http://example.org/fda/1875568148752541895,hasRecallReason,Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
http://example.org/fda/7306515815272079455,hasRecallReason,Lack of assurance of sterility
http://example.org/fda/8226254148337096749,hasRecallReason,"Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the product to contain undeclared diclofenac and methocarbamol,"
http://example.org/fda/1102543250002933575,hasRecallType,Class III
http://example.org/fda/7651084864701718490,hasRecallType,Class II
http://example.org/fda/3771838544264333003,hasRecallReason,Lack of assurance of sterility.
http://example.org/fda/4954023695438095648,hasRecallReason,Microbial Contamination of Non-Sterile Products: firm's internal testing found certain lots of the product to be contaminated with Burkholderia contaminans and/or yeast and mold.
http://example.org/fda/4093127647695093331,hasRecallType,Class II
http://example.org/fda/493054932092291667,hasRecallType,Class II
http://example.org/fda/6361442044189741034,hasRecallType,Class II
http://example.org/fda/1096445014040072361,hasRecallReason,"Labeling: Label Mixup; HYOSCYAMINE SULFATE ER Tablet, 0.375 mg may be potentially mislabeled as    SERTRALINE HCL, Tablet, 50 mg, NDC 16714061204, Pedigree: W003575, EXP: 6/24/2014."
http://example.org/fda/2520505044943007248,hasRecallType,Class II
http://example.org/fda/9081064596273475359,hasRecallType,Class II
http://example.org/fda/9012885002082907428,hasRecallReason,"Labeling: Label Mixup; carBAMazepine ER Tablet, 200 mg may be potentially mislabeled as    ACARBOSE, Tablet, 25 mg, NDC 00054014025, Pedigree: AD60272_1, EXP: 5/22/2014."
http://example.org/fda/1768054811115445307,hasRecallReason,Lack of sterility assurance.
http://example.org/fda/1979897119976148954,hasRecallType,Class II
http://example.org/fda/218418596035146660,hasRecallReason,Lack of sterility assurance.
http://example.org/fda/1251626105890658143,hasRecallReason,cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
http://example.org/fda/8599071242351272254,hasRecallType,Class II
http://example.org/fda/1272650815514195936,hasRecallReason,CGMP Deviations: Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.
http://example.org/fda/5500308585260750163,hasRecallType,Class II
http://example.org/fda/3104292743355712900,hasRecallReason,CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
http://example.org/fda/5755876587615066622,hasRecallType,Class II
http://example.org/fda/535500938967534586,hasRecallReason,"Labeling: Label Mix-Up: Bayer is recalling all Alka-Seltzer Plus packages, with a green or orange Bayer logo located on the lower left corner of the front of the carton, because the ingredients on the front sticker may not match the actual product in the carton."
http://example.org/fda/4267180201162481758,hasRecallType,Class II
http://example.org/fda/4910558732640097841,hasRecallType,Class II
http://example.org/fda/3904107516312965404,hasRecallReason,Failed Dissolution Specifications:
http://example.org/fda/4308512473708620652,hasRecallReason,CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.
http://example.org/fda/7402034824164743040,hasRecallType,Class I
http://example.org/fda/2430909607703648061,hasRecallReason,"Labeling: Not Elsewhere Classified: Schedule IV controlled substance indicator of CIV being omitted  from the product carton, primary label is correct."
http://example.org/fda/6065238165430783693,hasRecallReason,Lack of Processing Control
http://example.org/fda/4828232917996212801,hasRecallType,Class II
http://example.org/fda/5981827750348432717,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/1911328013464567806,hasRecallType,Class I
http://example.org/fda/3819959402594443542,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/1315141679511226287,hasRecallType,Class II
http://example.org/fda/4440332540343096274,hasRecallReason,cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
http://example.org/fda/5900744193658228783,hasRecallReason,Cross contamination with other products.
http://example.org/fda/2643107810326183982,hasRecallType,Class II
http://example.org/fda/978074343469614274,hasRecallReason,Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.
http://example.org/fda/807125466588240142,hasRecallReason,CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
http://example.org/fda/9138474149610599268,hasRecallReason,Failed Dissolution Specifications
http://example.org/fda/2074380231606225639,hasRecallReason,Lack of sterility assurance.
http://example.org/fda/1723451817026207674,hasRecallReason,Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
http://example.org/fda/6577671950966881216,hasRecallType,Class II
http://example.org/fda/3070072058419991737,hasRecallType,Class II
http://example.org/fda/1204053272162117707,hasRecallType,Class II
http://example.org/fda/5425169482696214973,hasRecallReason,"Presence of Precipitate; white substance confirmed as Guaifenesin, an active ingredient was observed in some bottles.  If the product is shaken or warmed the white particles goes into the solution."
http://example.org/fda/7552117853905955634,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/5676131448971395090,hasRecallReason,Failed Stability Specifications: Product exceeds compendia and firm's specifications for iron content.
http://example.org/fda/4717151341814130386,hasRecallReason,Lack of sterility assurance.
http://example.org/fda/569709651612491444,hasRecallType,Class II
http://example.org/fda/784411093478047629,hasRecallType,Class II
http://example.org/fda/7184603922938632485,hasRecallType,Class II
http://example.org/fda/8719443964613560659,hasRecallReason,Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.
http://example.org/fda/3144607871300739461,hasRecallReason,Microbial contamination
http://example.org/fda/7898922859350630757,hasRecallReason,Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.
http://example.org/fda/4851856758084143460,hasRecallReason,Lack of sterility assurance.
http://example.org/fda/901679399558518357,hasRecallType,Class II
http://example.org/fda/8376932507743173970,hasRecallType,Class II
http://example.org/fda/6121598793798201419,hasRecallReason,CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
http://example.org/fda/6915699957444766852,hasRecallReason,Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
http://example.org/fda/9122297284803826350,hasRecallReason,Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
http://example.org/fda/1939894870249384041,hasRecallType,Class II
http://example.org/fda/2220534005407539014,hasRecallReason,Failed Impurities/Degradation Specifications
http://example.org/fda/2779807000609768061,hasRecallType,Class II
http://example.org/fda/2112507474873126220,hasRecallReason,CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.
http://example.org/fda/7810487455928626104,hasRecallReason,Subpotent (Single Ingredient Drug): out-of-specification result for coal tar content assay.
http://example.org/fda/3111877544215018650,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/6577671950966881216,hasRecallReason,CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.
http://example.org/fda/6449620314837304768,hasRecallReason,Labeling: Wrong Bar Code; Bar code scans as 0.15% Potassium Chloride in 0.9% Sodium Chloride (20 mEq K/liter).
http://example.org/fda/1771820347314741383,hasRecallType,Class II
http://example.org/fda/802353277516011323,hasRecallReason,The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
http://example.org/fda/4825262524533875588,hasRecallReason,Lack of sterility assurance
http://example.org/fda/3312214653122391137,hasRecallReason,Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
http://example.org/fda/6942662919773165782,hasRecallReason,Subpotent Drug
http://example.org/fda/5893326288380482547,hasRecallType,Class II
http://example.org/fda/955339659132797166,hasRecallReason,CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.
http://example.org/fda/6058470966368382925,hasRecallReason,Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.
http://example.org/fda/4170167411207141712,hasRecallType,Class II
http://example.org/fda/5674271140358429152,hasRecallReason,Labeling: Incorrect or Missing Lot and/or Exp Date - the label contains an incorrect Exp Date.
http://example.org/fda/3410941493983630141,hasRecallReason,Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.
http://example.org/fda/7292430894180563394,hasRecallReason,Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products
http://example.org/fda/569709651612491444,hasRecallReason,Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
http://example.org/fda/5210319473007162210,hasRecallType,Class II
http://example.org/fda/961621477717987553,hasRecallType,Class II
http://example.org/fda/8918426301499513668,hasRecallType,Class II
http://example.org/fda/6028148081480805065,hasRecallType,Class II
http://example.org/fda/506949931979825049,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/601280916201586996,hasRecallType,Class II
http://example.org/fda/3982123762646105362,hasRecallReason,Labeling: Incorrect or Missing Package Insert
http://example.org/fda/2171944192554663996,hasRecallReason,Lack of Assurance of Sterility: Due to lack of documentation of proper environmental monitoring during the time in which the medication was produced.
http://example.org/fda/5950012287356101220,hasRecallType,Class I
http://example.org/fda/7358560234442454392,hasRecallReason,"Failed Impurities/Degradation Specifications: Sub-recall because this repackaged product was recalled by the manufacturing firm, Wockhardt, due to out-of-specification results for the Enalapril DiKetopiperazine degradation product."
http://example.org/fda/77044880742775769,hasRecallReason,CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.
http://example.org/fda/3231271667348113452,hasRecallType,Class II
http://example.org/fda/8151484814589467336,hasRecallType,Class II
http://example.org/fda/7437952646629275180,hasRecallType,Class III
http://example.org/fda/245020545821731717,hasRecallReason,cGMP deviations: Temperature abuse
http://example.org/fda/3203142304938622972,hasRecallType,Class III
http://example.org/fda/8309216060679564868,hasRecallType,Class II
http://example.org/fda/1179963588127312615,hasRecallType,Class II
http://example.org/fda/144958799957545750,hasRecallType,Class II
http://example.org/fda/3560040415784043132,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/3736690743238649517,hasRecallType,Class II
http://example.org/fda/5332580006076973578,hasRecallReason,Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
http://example.org/fda/7593616477996465105,hasRecallType,Class II
http://example.org/fda/8096994186035048767,hasRecallType,Class II
http://example.org/fda/4267180201162481758,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/7079629904659284886,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/8591485834352018879,hasRecallReason,Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
http://example.org/fda/7928631525664976303,hasRecallType,Class II
http://example.org/fda/213916844099382172,hasRecallType,Class II
http://example.org/fda/8006955713321384004,hasRecallReason,Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
http://example.org/fda/5994813998653094599,hasRecallReason,Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
http://example.org/fda/3674046587181268177,hasRecallType,Class II
http://example.org/fda/4548303374376805620,hasRecallType,Class II
http://example.org/fda/5718722333286950597,hasRecallReason,CGMP Deviations: product held outside appropriate storage temperature conditions.
http://example.org/fda/245020545821731717,hasRecallType,Class II
http://example.org/fda/822843178695061180,hasRecallReason,Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.
http://example.org/fda/865608484984024924,hasRecallType,Class II
http://example.org/fda/8952123424139634772,hasRecallType,Class II
http://example.org/fda/6703769736985405058,hasRecallType,Class II
http://example.org/fda/4841523879702864745,hasRecallType,Class II
http://example.org/fda/7395879652974158428,hasRecallType,Class II
http://example.org/fda/3959948659798033064,hasRecallType,Class I
http://example.org/fda/7417088806130813289,hasRecallReason,Lack of Assurance of Sterility; product has the potential to leak.
http://example.org/fda/1056908010275815781,hasRecallReason,cGMP deviations: Temperature abuse
http://example.org/fda/7448981148540570954,hasRecallType,Class II
http://example.org/fda/4059109629018375519,hasRecallType,Class II
http://example.org/fda/4155065152592579031,hasRecallType,Class II
http://example.org/fda/7593616477996465105,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/4375650157027340260,hasRecallReason,"Labeling: Label Mixup:CYANOCOBALAMIN, Tablet, 500 mcg was mislabled as SEVELAMER CARBONATE, Tablet, 800 mg, NDC 58468013001, Pedigree: W002859, EXP: 6/7/2014.  and may have potentially been mislabeled as one of the following drugs:  VITAMIN B COMPLEX W/C, Tablet, 0, NDC 00536730001, Pedigree: AD52993_7, EXP: 5/20/2014;  CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00536355601, Pedigree: AD30180_22, EXP:"
http://example.org/fda/7911913443890490842,hasRecallReason,"Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches."
http://example.org/fda/6472191523837515629,hasRecallReason,"Presence of Precipitate; white substance confirmed as Guaifenesin, an active ingredient was observed in some bottles."
http://example.org/fda/2741100406574262343,hasRecallType,Class II
http://example.org/fda/7730603113499093964,hasRecallReason,Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
http://example.org/fda/3119980038927059285,hasRecallType,Class II
http://example.org/fda/2694206862589082587,hasRecallReason,Failed Impurities/Degradation Specification -This recall is being initiated as a precaution due to the presence of an unknown impurity observed during shelf life of the product.
http://example.org/fda/7567765359486034891,hasRecallReason,CGMP DEVIATIONS
http://example.org/fda/6390140328665765837,hasRecallType,Class II
http://example.org/fda/8142661991236998631,hasRecallReason,Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
http://example.org/fda/9184314195971090633,hasRecallType,Class III
http://example.org/fda/8925976648757933676,hasRecallType,Class III
http://example.org/fda/8934674337478009664,hasRecallType,Class II
http://example.org/fda/8055078509795384668,hasRecallType,Class II
http://example.org/fda/5923870180580026033,hasRecallReason,Presence of Particulate Matter
http://example.org/fda/7735778202937274747,hasRecallReason,Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.
http://example.org/fda/6219776552541948343,hasRecallType,Class II
http://example.org/fda/5784823255997998884,hasRecallReason,Failed Impurities/Degradation Specifications: out-of-specification results for individual unknown and total impurity at the 12th month room temperature stability test station
http://example.org/fda/2798856790562113068,hasRecallReason,Lack of sterility assurance.
http://example.org/fda/4601122343221742857,hasRecallType,Class II
http://example.org/fda/3756325261639667478,hasRecallReason,Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.
http://example.org/fda/3724222658847333314,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/7584218321069905722,hasRecallReason,cGMP Deviations
http://example.org/fda/2464494917872510782,hasRecallType,Class II
http://example.org/fda/2708183172794967995,hasRecallType,Class II
http://example.org/fda/5037510865366524504,hasRecallReason,Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
http://example.org/fda/7181186276996619374,hasRecallReason,Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and and/or the z-statistic values.
http://example.org/fda/5007327090100214488,hasRecallReason,Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
http://example.org/fda/2166196728077041198,hasRecallReason,"Failed Stability Specifications: Out of specification for preservative, benazalkonium chloride."
http://example.org/fda/6779045115039554637,hasRecallType,Class II
http://example.org/fda/548898001590757248,hasRecallReason,"Labeling: Label Mixup; COENZYME Q-10 Capsule, 100 mg may be potentially mislabeled as    ASPIRIN EC, Tablet, 325 mg, NDC 00904201360, Pedigree: AD30180_13, EXP: 5/9/2014;  ASPIRIN, Chew Tablet, 81 mg, NDC 00536329736, Pedigree: AD33897_1, EXP: 5/9/2014;  TACROLIMUS, Capsule, 1 mg, NDC 00781210301, Pedigree: AD37056_1, EXP: 5/10/2014;  METOPROLOL TARTRATE, Tablet, 12.5 mg (1/2 of 25 mg), NDC 576640"
http://example.org/fda/8151149890906561762,hasRecallReason,Subpotent: Out of specification for assay at the 12-month time point.
http://example.org/fda/247127179553936082,hasRecallType,Class II
http://example.org/fda/5657611257221627394,hasRecallType,Class II
http://example.org/fda/684569185537998967,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/2248421706548036,hasRecallReason,Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
http://example.org/fda/6358868119992887589,hasRecallReason,cGMP Deviations; lack of quality assurance.
http://example.org/fda/3560040415784043132,hasRecallType,Class II
http://example.org/fda/3771838544264333003,hasRecallType,Class II
http://example.org/fda/480411883193762179,hasRecallType,Class II
http://example.org/fda/5969931315983264170,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/144723653439079097,hasRecallType,Class I
http://example.org/fda/2390849749745084705,hasRecallType,Class II
http://example.org/fda/8550422134425190541,hasRecallType,Class II
http://example.org/fda/3421464731706914491,hasRecallReason,Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.
http://example.org/fda/2411093456480000478,hasRecallType,Class III
http://example.org/fda/4024754069136194330,hasRecallReason,Lack of assurance of sterility.
http://example.org/fda/7365836569047675069,hasRecallReason,Lack of Processing Controls
http://example.org/fda/4538705385324184281,hasRecallType,Class II
http://example.org/fda/5969931315983264170,hasRecallType,Class II
http://example.org/fda/1172494217521998917,hasRecallReason,Lack of sterility assurance.
http://example.org/fda/1310862417664708363,hasRecallType,Class II
http://example.org/fda/6999866521459425431,hasRecallType,Class II
http://example.org/fda/3300757442547937559,hasRecallType,Class I
http://example.org/fda/4762575048112606615,hasRecallReason,Lack of Assurance of Sterility: There are also CGMP Deviations.
http://example.org/fda/3801973635739011813,hasRecallReason,Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
http://example.org/fda/6072312473414204695,hasRecallType,Class II
http://example.org/fda/3847654338540877244,hasRecallType,Class I
http://example.org/fda/7852960911973289513,hasRecallReason,Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.
http://example.org/fda/4318404211497386751,hasRecallType,Class II
http://example.org/fda/113406432808017985,hasRecallReason,Some bottles may contain mixed strengths of the product.
http://example.org/fda/7384192574707506022,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/6646779126803047045,hasRecallType,Class II
http://example.org/fda/6181519712976965565,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/2430909607703648061,hasRecallType,Class III
http://example.org/fda/7649651296643174304,hasRecallType,Class III
http://example.org/fda/354073496021671299,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/9000806366982265534,hasRecallReason,Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule
http://example.org/fda/3060698260435226912,hasRecallReason,Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
http://example.org/fda/1921637079920383958,hasRecallType,Class II
http://example.org/fda/7093880530978191192,hasRecallReason,Presence of Particulate Matter: Silicone
http://example.org/fda/7695680700153184096,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/6257855946111386300,hasRecallType,Class II
http://example.org/fda/3571207339052060897,hasRecallType,Class II
http://example.org/fda/5528307156123729586,hasRecallType,Class II
http://example.org/fda/5081223102235582558,hasRecallReason,Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.
http://example.org/fda/6566674024284106046,hasRecallReason,"Labeling: Label Mixup: PHENYTOIN SODIUM ER, Capsule, 30 mg may have potentially been mislabeled as the following drug:  LITHIUM CARBONATE ER, Tablet, 450 mg, NDC 00054002025, Pedigree: W003327, EXP: 6/19/2014."
http://example.org/fda/8599071242351272254,hasRecallReason,Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
http://example.org/fda/4760890197892112870,hasRecallType,Class II
http://example.org/fda/4868593575639021811,hasRecallType,Class I
http://example.org/fda/868715377019234251,hasRecallReason,Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer
http://example.org/fda/5632550269913311997,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/1299052528111628195,hasRecallReason,Non Sterility: Microbial contamination
http://example.org/fda/7917913277102164594,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/1390928786270389761,hasRecallType,Class II
http://example.org/fda/207698867015919738,hasRecallType,Class II
http://example.org/fda/8366006662348132839,hasRecallType,Class II
http://example.org/fda/1969904906187256980,hasRecallReason,Lack of assurance of sterility
http://example.org/fda/3176207947426967671,hasRecallReason,Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling includes drug claims to act as an antidote.
http://example.org/fda/1079589632980267272,hasRecallType,Class II
http://example.org/fda/4612132844597846209,hasRecallType,Class II
http://example.org/fda/551409117624238169,hasRecallType,Class II
http://example.org/fda/3860153084416413918,hasRecallReason,Superpotent Drug: Out of specification for assay at the 12-month timepoint.
http://example.org/fda/4604401595944914403,hasRecallReason,Failed Impurities/Degradation Specifications
http://example.org/fda/5532118654308936721,hasRecallType,Class II
http://example.org/fda/1224308298099071637,hasRecallReason,"Failed Impurities/Degradation Specifications: high out of specification results for one of the known degradation products, m-chlorobenzoic acid."
http://example.org/fda/950430504400370474,hasRecallType,Class II
http://example.org/fda/2081649352942348274,hasRecallReason,CGMP Deviations: recalling drug products following an FDA inspection.
http://example.org/fda/5128625117207820061,hasRecallType,Class III
http://example.org/fda/5804915747283553758,hasRecallType,Class II
http://example.org/fda/932411233529475539,hasRecallType,Class II
http://example.org/fda/7610864536928855936,hasRecallReason,Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.
http://example.org/fda/83030617995930616,hasRecallType,Class II
http://example.org/fda/7192617236412831821,hasRecallType,Class II
http://example.org/fda/4030193939023709749,hasRecallReason,Failed Dissolution Specifications: low out-of-specification dissolution test results observed.
http://example.org/fda/1551966173709212992,hasRecallType,Class I
http://example.org/fda/524001158104578457,hasRecallType,Class II
http://example.org/fda/2447020681124857802,hasRecallReason,Defective Delivery System
http://example.org/fda/499510870795889777,hasRecallReason,Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle.
http://example.org/fda/8021671372545143323,hasRecallType,Class II
http://example.org/fda/3261929987364887233,hasRecallType,Class II
http://example.org/fda/8599333852752991943,hasRecallReason,Lack of Assurance of Sterility.
http://example.org/fda/2513335163414514861,hasRecallReason,cGMP Deviations: Products were stored outside the drug label specifications.
http://example.org/fda/2437068810768017052,hasRecallType,Class II
http://example.org/fda/493054932092291667,hasRecallReason,Lack of Assurance of Sterility: There are also CGMP Deviations.
http://example.org/fda/6484594729071229774,hasRecallReason,Lack of sterility assurance.
http://example.org/fda/6967552668902703089,hasRecallType,Class I
http://example.org/fda/5063486099511788002,hasRecallReason,"Labeling: Missing Label-Primary packaging label (i.e. blister card) is blank and contains no product information (e.g. product name, strength, lot number, expiry)."
http://example.org/fda/8672548745410197563,hasRecallReason,Microbial contamination
http://example.org/fda/6443094582852906059,hasRecallType,Class II
http://example.org/fda/4788675635256854447,hasRecallType,Class II
http://example.org/fda/1023978312407414319,hasRecallType,Class II
http://example.org/fda/584125729254737492,hasRecallReason,Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.
http://example.org/fda/1979897119976148954,hasRecallReason,Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.
http://example.org/fda/4015576655035492370,hasRecallType,Class II
http://example.org/fda/248158152011171121,hasRecallType,Class I
http://example.org/fda/6658254833523180445,hasRecallReason,CGMP Deviations: recalling drug products following an FDA inspection.
http://example.org/fda/6739715503406538176,hasRecallReason,Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine
http://example.org/fda/5638311776022982389,hasRecallReason,Lack of Assurance of Sterility: Some single-use vials may be filled with water rather than the product solution and the firm cannot guarantee the sterility of the water-filled vials.
http://example.org/fda/2087459445908410549,hasRecallReason,Microbial contamination
http://example.org/fda/8404214759353557102,hasRecallType,Class II
http://example.org/fda/2421440890687676852,hasRecallReason,Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
http://example.org/fda/1897486392564975113,hasRecallReason,Superpotent Drug
http://example.org/fda/3160872010014452108,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/6610733891885524320,hasRecallType,Class II
http://example.org/fda/1236043666039942121,hasRecallReason,"Presence of  foreign tablets/capsules: Ibuprofen Tablets USP, 600 mg bottles were found to contain some Ibuprofen Tablets USP 800 mg."
http://example.org/fda/5696610804951808665,hasRecallType,Class II
http://example.org/fda/4998519183063738309,hasRecallType,Class III
http://example.org/fda/2834377656840734409,hasRecallReason,Superpotent; Hydrochlorothiazide
http://example.org/fda/6285672385241867170,hasRecallReason,Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
http://example.org/fda/5036334514835396096,hasRecallReason,CGMP Deviations
http://example.org/fda/7889868166062486230,hasRecallReason,Lack of Assurance of Sterility:  Bag has the potential to leak.
http://example.org/fda/1396635294283147577,hasRecallType,Class II
http://example.org/fda/1201385077615987523,hasRecallType,Class II
http://example.org/fda/6257855946111386300,hasRecallReason,Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.
http://example.org/fda/5554058617903510357,hasRecallType,Class II
http://example.org/fda/6597559151259162576,hasRecallType,Class II
http://example.org/fda/5569038685815214013,hasRecallReason,Lack of sterility assurance
http://example.org/fda/1301868974062475192,hasRecallType,Class II
http://example.org/fda/2589585735257093193,hasRecallType,Class II
http://example.org/fda/3571207339052060897,hasRecallReason,The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
http://example.org/fda/6126084707546764376,hasRecallReason,Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.
http://example.org/fda/4220185341973768704,hasRecallReason,Presence of Foreign Tablets: Presence of atenolol 25 mg tablet mixed into promethazine 25 mg tablet bottles.
http://example.org/fda/5313615534925033782,hasRecallReason,Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
http://example.org/fda/3955711492672179027,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/774272886333321849,hasRecallType,Class II
http://example.org/fda/4361845737108872835,hasRecallReason,Failed Stability Specifications
http://example.org/fda/2162029150018319029,hasRecallType,Class II
http://example.org/fda/4008302843810316438,hasRecallType,Class II
http://example.org/fda/462513346638658439,hasRecallReason,CGMP Deviations: products manufactured under conditions that could impact its product quality.
http://example.org/fda/7444151208341206574,hasRecallReason,cGMP deviations: Temperature abuse
http://example.org/fda/2365812774855526817,hasRecallType,Class II
http://example.org/fda/2227476994621402652,hasRecallReason,The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
http://example.org/fda/103915713868924780,hasRecallReason,Presence of Particulate; lot being recalled as a precaution due to the discovery of 2 particles found in a lot which preceded the recalled lot
http://example.org/fda/2018241912162728491,hasRecallReason,Lack of sterility assurance.
http://example.org/fda/293723083197211011,hasRecallReason,Lack of sterility assurance
http://example.org/fda/2666576358243555232,hasRecallType,Class II
http://example.org/fda/1655000515399706742,hasRecallReason,Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
http://example.org/fda/5543349536102650131,hasRecallReason,"CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million."
http://example.org/fda/4825262524533875588,hasRecallType,Class II
http://example.org/fda/6380879745559320981,hasRecallType,Class II
http://example.org/fda/6443094582852906059,hasRecallReason,"Labeling: Label Mixup; PROPRANOLOL HCL, Tablet, 10 mg may be potentially mislabeled as    PIOGLITAZONE HCL, Tablet, 15 mg, NDC 00093204856, Pedigree: AD52778_70, EXP: 5/21/2014."
http://example.org/fda/615150850813001547,hasRecallReason,Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
http://example.org/fda/1776311039531520613,hasRecallType,Class II
http://example.org/fda/6285672385241867170,hasRecallType,Class II
http://example.org/fda/6881746128778993052,hasRecallType,Class II
http://example.org/fda/5343501027616207810,hasRecallReason,"Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes."
http://example.org/fda/4240272725379959,hasRecallReason,Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.
http://example.org/fda/5177900552097081525,hasRecallType,Class I
http://example.org/fda/2731735105313469750,hasRecallType,Class II
http://example.org/fda/5561028994546941113,hasRecallType,Class II
http://example.org/fda/1234977498889291382,hasRecallReason,CGMP Deviations:
http://example.org/fda/773622596342044557,hasRecallReason,CGMP Deviations: Firm went out of business and could no longer continue stability studies.
http://example.org/fda/7444151208341206574,hasRecallType,Class II
http://example.org/fda/3130222742580391108,hasRecallReason,CGMP deviations: Lack of potency testing.
http://example.org/fda/7186999475051394869,hasRecallType,Class II
http://example.org/fda/1568245460947253992,hasRecallType,Class II
http://example.org/fda/7604283748251002757,hasRecallType,Class II
http://example.org/fda/9153031696169683805,hasRecallReason,"Labeling:Label Mix-up: Shipper Carton labelled Testosterone Cypionate Injection, USP, 200mg/mL, 1 ml single-dose  vials, found to contain shelf cartons labelled as Testosterone Cypionate Injection USP, 200mg/mL, 10 ml  multi-dose vials which contain Testosterone Cypionate Injection USP, 200mg/mL,1mL single-does vials"
http://example.org/fda/4975216298174330233,hasRecallReason,Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.
http://example.org/fda/8066816553310098258,hasRecallReason,Failed Impurities/Degradation Specifications: High out of specification results for related compounds.
http://example.org/fda/2162029150018319029,hasRecallReason,Defective Container: Confirmed customer complaints of leaking bottles.
http://example.org/fda/7380844040959250361,hasRecallReason,Penicillin Cross Contamination: potentially contaminated with penicillin
http://example.org/fda/6989254231324878005,hasRecallReason,Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
http://example.org/fda/8919154840340465713,hasRecallReason,Adulterated Presence of Foreign Tablets: This product is being recalled becaiuse 30 valacyclovir hydrochloride tablets USP 500 mg were discovered in a bottle labeled Zolpidem Tartrate tables USP 10 mg
http://example.org/fda/1725727208492952978,hasRecallType,Class I
http://example.org/fda/7773860314772784832,hasRecallReason,Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
http://example.org/fda/3601249222347075583,hasRecallType,Class II
http://example.org/fda/302162446670228998,hasRecallReason,Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
http://example.org/fda/6848513816747356216,hasRecallReason,"Stability testing failures for one or two of the four active pharmaceutical ingredients among the finished drug products, i.e., Phenylephrine HCL, and/or Chlorpheniramine Maleate."
http://example.org/fda/4398828639649045363,hasRecallType,Class II
http://example.org/fda/4196780542329821226,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/3189993510889945638,hasRecallType,Class II
http://example.org/fda/7749554141085876186,hasRecallType,Class II
http://example.org/fda/5412940737425986246,hasRecallType,Class II
http://example.org/fda/5506843099378336186,hasRecallReason,CGMP Deviations: products manufactured under conditions that could impact its product quality.
http://example.org/fda/2032493010192080440,hasRecallType,Class II
http://example.org/fda/2395250721566481373,hasRecallReason,Failed Dissolution Specifications: Low dissolution results were obtained during stability testing
http://example.org/fda/4254649878222414558,hasRecallType,Class II
http://example.org/fda/5893326288380482547,hasRecallReason,Lack of assurance of sterility:
http://example.org/fda/791843767175721890,hasRecallType,Class II
http://example.org/fda/2966914026615335650,hasRecallReason,Superpotent Drug.
http://example.org/fda/4533063859408315425,hasRecallType,Class II
http://example.org/fda/150529202784823430,hasRecallType,Class II
http://example.org/fda/2731735105313469750,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/7192617236412831821,hasRecallReason,Good Manufacturing Practices Deviations: The product has an Active Pharmaceutical Ingredient from an unapproved source.
http://example.org/fda/6133968909350564007,hasRecallReason,Presence of particulate matter: visible free floating and partially embedded particulate matter in the glass vials.
http://example.org/fda/8667424537466132224,hasRecallReason,Lack of assurance of sterility.
http://example.org/fda/1832401432115232977,hasRecallReason,Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
http://example.org/fda/2437068810768017052,hasRecallReason,The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
http://example.org/fda/7057521967548770484,hasRecallReason,cGMP deviations: Temperature abuse
http://example.org/fda/2457401731003850597,hasRecallReason,CGMP Deviations: Product complaints received indicating reconstituted suspension was observed to be thick.
http://example.org/fda/4828440713060101927,hasRecallType,Class II
http://example.org/fda/7411640827213560775,hasRecallType,Class II
http://example.org/fda/3024017178754014875,hasRecallReason,Lack of sterility assurance.
http://example.org/fda/5561028994546941113,hasRecallReason,"Labeling: Label Mixup: FLUCONAZOLE, Tablet, 200 mg may have potentially been mislabeled as one of the following drugs:  VALSARTAN, Tablet, 80 mg, NDC 00078035834, Pedigree: AD65475_10, EXP: 5/28/2014;  FLUCONAZOLE, Tablet, 100 mg, NDC 68462010230, Pedigree: W003064, EXP: 6/12/2014."
http://example.org/fda/3204354474524368601,hasRecallType,Class II
http://example.org/fda/3759316319569653506,hasRecallReason,"Chemical contamination: product found to be contaminated with methanol (wood alcohol), benzene and acetaldehyde."
http://example.org/fda/8885753467179844788,hasRecallType,Class II
http://example.org/fda/412761485132398469,hasRecallReason,Failed Tablet/Capsule Specifications: Broken tablets
http://example.org/fda/147079419507402646,hasRecallType,Class II
http://example.org/fda/1313217515812686071,hasRecallType,Class III
http://example.org/fda/361511668132543512,hasRecallType,Class II
http://example.org/fda/527711001754493471,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/6466460185248198641,hasRecallReason,"CGMP Deviations: Voluntary recall of all hand sanitizer distributed after March 31, 2022, due to FDA issued guidance to cease placing hand sanitizer product, produced under temporary approval, into the market after March 31, 2022."
http://example.org/fda/7622867679896580283,hasRecallReason,Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.
http://example.org/fda/6121272220678175903,hasRecallType,Class II
http://example.org/fda/3023518649065572758,hasRecallType,Class II
http://example.org/fda/4308512473708620652,hasRecallType,Class II
http://example.org/fda/380865023867704079,hasRecallType,Class II
http://example.org/fda/5791359471110924336,hasRecallType,Class II
http://example.org/fda/4875810011603677538,hasRecallReason,"Marketed Without An Approved NDA/ANDA: FDA analyses detected the presence of phenolphthalein, N-di-Desmethylsibutramine, and trace amounts of sibutramine and N-Desmethylsibutramine. Sibutramine and phenolphthalein were previously available drug products but were removed from the U.S. market making these products unapproved new drugs."
http://example.org/fda/6300108709477772567,hasRecallType,Class II
http://example.org/fda/880552124706594358,hasRecallType,Class II
http://example.org/fda/1568245460947253992,hasRecallReason,"Labeling: Label Mixup: AMANTADINE HCL, Capsule, 100 mg may have potentially been mislabeled as one of the following drugs:  ACARBOSE, Tablet, 25 mg, NDC 00054014025, Pedigree: W002725, EXP: 6/6/2014;  clomiPRAMINE HCl, Capsule, 50 mg, NDC 51672401205, Pedigree: W002998, EXP: 6/11/2014;  ASPIRIN EC DR, Tablet, 81 mg, NDC 49348098015, Pedigree: W003672, EXP: 2/28/2014;  NIACIN TR, Capsule, 500 mg, N"
http://example.org/fda/3414762844157630710,hasRecallType,Class II
http://example.org/fda/5804915747283553758,hasRecallReason,Failed Dissolution Specification
http://example.org/fda/4024754069136194330,hasRecallType,Class II
http://example.org/fda/8602488976472629784,hasRecallType,Class II
http://example.org/fda/2774179521716024027,hasRecallReason,"Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil, making AMPD GOLD an unapproved drug."
http://example.org/fda/7219561343306685358,hasRecallType,Class II
http://example.org/fda/4018690629158556480,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/5620809164419447569,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/8510928336444912208,hasRecallType,Class II
http://example.org/fda/8494692318245838651,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/7913856060397561225,hasRecallReason,Lack of Assurance of Sterility.
http://example.org/fda/5652288039196341971,hasRecallType,Class II
http://example.org/fda/2585397172436601971,hasRecallReason,Subpotent Drug: Product does not contain SPF that is declared on the label.
http://example.org/fda/8478545332244712024,hasRecallType,Class II
http://example.org/fda/1561244364922988843,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/6596645292575076963,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/499510870795889777,hasRecallType,Class II
http://example.org/fda/6596645292575076963,hasRecallType,Class II
http://example.org/fda/2659203345960568091,hasRecallType,Class II
http://example.org/fda/6324121879583560650,hasRecallReason,Lack of Assurance of Sterility.
http://example.org/fda/8189869196326965490,hasRecallType,Class II
http://example.org/fda/6121272220678175903,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/5855788380455879197,hasRecallReason,Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.
http://example.org/fda/3256821052236207449,hasRecallType,Class II
http://example.org/fda/7495054917327794968,hasRecallReason,Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters
http://example.org/fda/7010191538042121875,hasRecallReason,Failed Dissolution Specifications
http://example.org/fda/3850700804033629895,hasRecallReason,CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.
http://example.org/fda/5101058828775077661,hasRecallType,Class II
http://example.org/fda/3309978395713298308,hasRecallType,Class II
http://example.org/fda/6498143986517988148,hasRecallReason,Lack of Assurance of Sterility: Deformed stoppers observed during filling operations for Cathflo Activase.
http://example.org/fda/7567765359486034891,hasRecallType,Class II
http://example.org/fda/2111500875826595784,hasRecallReason,CGMP Deviations
http://example.org/fda/1393979656638794139,hasRecallReason,Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
http://example.org/fda/1359675142966164878,hasRecallReason,Labeling: Incorrect or Missing Lot and/or Exp Date: Incorrect expiration date on label
http://example.org/fda/6300108709477772567,hasRecallReason,Presence of Particulate Matter: visible crystalline particulates and the discovery of crystalline particulate in a retain sample.
http://example.org/fda/349952965678531528,hasRecallReason,Non-Sterility; mold contamination
http://example.org/fda/6027285311141684691,hasRecallType,Class III
http://example.org/fda/8880211010646448966,hasRecallReason,Microbial contamination
http://example.org/fda/2600722204916718453,hasRecallType,Class II
http://example.org/fda/8574929738884873953,hasRecallType,Class II
http://example.org/fda/7386282713951254803,hasRecallReason,Failed Stability Specifications:Out-of-specification results observed for viscosity during stability testing.
http://example.org/fda/7483666591034232468,hasRecallType,Class III
http://example.org/fda/1277625452476818102,hasRecallReason,Microbial contamination
http://example.org/fda/4701010981418368259,hasRecallType,Class II
http://example.org/fda/6133968909350564007,hasRecallType,Class I
http://example.org/fda/827186348346506484,hasRecallReason,CGMP Deviations: Intermittent exposure to temperature excursion during storage.
http://example.org/fda/8789060004081577930,hasRecallType,Class II
http://example.org/fda/597204405460573759,hasRecallType,Class II
http://example.org/fda/3788392631936515869,hasRecallReason,Tablets/Capsules Imprinted with Wrong ID: Some tablets incorrectly imprinted with an X on one side.
http://example.org/fda/6123860992453410513,hasRecallReason,Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.
http://example.org/fda/2048391439144541711,hasRecallType,Class III
http://example.org/fda/3945675688021086900,hasRecallType,Class II
http://example.org/fda/2378675205373916965,hasRecallType,Class II
http://example.org/fda/7716552703488206757,hasRecallType,Class II
http://example.org/fda/4030193939023709749,hasRecallType,Class II
http://example.org/fda/8024893346869080467,hasRecallType,Class II
http://example.org/fda/2081649352942348274,hasRecallType,Class II
http://example.org/fda/5698948276666014329,hasRecallType,Class II
http://example.org/fda/5040708705614820339,hasRecallType,Class I
http://example.org/fda/7341074522472824555,hasRecallReason,Microbial Contamination of Non-Sterile Products
http://example.org/fda/1712149109145247206,hasRecallReason,CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.
http://example.org/fda/6647076918072562880,hasRecallReason,Penicillin Cross Contamination: potentially contaminated with penicillin
http://example.org/fda/5565693097234589125,hasRecallType,Class II
http://example.org/fda/7483666591034232468,hasRecallReason,Presence of Foreign Tablets/Capsules: Pharmacist reported presence of some Gabapentin tablets 800 mg comingled in Gabapentin 600 mg 500 count bottles.
http://example.org/fda/5718722333286950597,hasRecallType,Class II
http://example.org/fda/5784823255997998884,hasRecallType,Class III
http://example.org/fda/7610864536928855936,hasRecallType,Class II
http://example.org/fda/3879450826944235769,hasRecallType,Class II
http://example.org/fda/439547629257852353,hasRecallType,Class II
http://example.org/fda/6481975180585984341,hasRecallType,Class II
http://example.org/fda/3505620858739787051,hasRecallReason,CGMP Deviations: potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.
http://example.org/fda/3804091836034310382,hasRecallType,Class II
http://example.org/fda/1497608214591708034,hasRecallType,Class II
http://example.org/fda/8946719827052792763,hasRecallReason,"Labeling: Label Mixup; diphenhydrAMINE HCl, Tablet, 25 mg may be potentially mislabeled as     ATORVASTATIN CALCIUM, Tablet, 40 mg, NDC 00378212177, Pedigree: AD33897_10, EXP: 5/9/2014;  ATORVASTATIN CALCIUM, Tablet, 10 mg, NDC 00378201577, Pedigree: W002774, EXP: 6/6/2014;  PRENATAL MULTIVITAMIN/ MULTIMINERAL, Tablet, NDC 51991056601, Pedigree: W003511, EXP: 6/21/2014;  VENLAFAXINE, Tablet, 25 mg"
http://example.org/fda/1559866602416670158,hasRecallReason,Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
http://example.org/fda/1646071971136916371,hasRecallType,Class II
http://example.org/fda/2093943912642850078,hasRecallReason,Underfilled units.
http://example.org/fda/1719221022662843765,hasRecallType,Class II
http://example.org/fda/4216340970571680203,hasRecallType,Class II
http://example.org/fda/7234652138346976662,hasRecallReason,Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product
http://example.org/fda/2303527139057175559,hasRecallType,Class II
http://example.org/fda/5721101016892001380,hasRecallReason,Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products
http://example.org/fda/1956654487315858252,hasRecallReason,Presence of Particulate Matter - found in reserve sample vials at the firm.
http://example.org/fda/8071332324481361482,hasRecallType,Class II
http://example.org/fda/3945675688021086900,hasRecallReason,Lack of Assurance of Sterility: Complaints of syringe breakage
http://example.org/fda/6925917211625221911,hasRecallReason,"Chemical Contamination: FDA analysis found 1 lot of MEDICALLY MINDED Hand Sanitizer Gel, ANTIMICROBIAL FORMULA (ethyl alcohol 70%) to be below the label claim for ethanol content and to contain methanol."
http://example.org/fda/732811141567878642,hasRecallType,Class II
http://example.org/fda/2513335163414514861,hasRecallType,Class II
http://example.org/fda/1329284162774571968,hasRecallType,Class II
http://example.org/fda/5907249398687717953,hasRecallReason,Microbial contamination
http://example.org/fda/1291252698137508810,hasRecallReason,Lack of Assurance of Sterility; Immediate product pouches may not be properly sealed.
http://example.org/fda/5554058617903510357,hasRecallReason,Lack of Assurance of Sterility: There are also CGMP Deviations.
http://example.org/fda/5721082521137704356,hasRecallType,Class III
http://example.org/fda/6617486493720301872,hasRecallType,Class II
http://example.org/fda/6658254833523180445,hasRecallType,Class II
http://example.org/fda/8600981381846112799,hasRecallType,Class II
http://example.org/fda/2048391439144541711,hasRecallReason,Failed Impurities/ Degradation Specifications
http://example.org/fda/1605384624851643993,hasRecallType,Class III
http://example.org/fda/7306515815272079455,hasRecallType,Class II
http://example.org/fda/1310862417664708363,hasRecallReason,CGMP Deviations: Presence of NDMA impurity detected in product.
http://example.org/fda/7386282713951254803,hasRecallType,Class III
http://example.org/fda/2150566307569001448,hasRecallReason,"cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected."
http://example.org/fda/8055078509795384668,hasRecallReason,cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
http://example.org/fda/9222906428059805922,hasRecallReason,Microbial contamination
http://example.org/fda/2466486231086950428,hasRecallReason,Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine
http://example.org/fda/7980330501869601697,hasRecallReason,CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs
http://example.org/fda/694549865638933056,hasRecallType,Class III
http://example.org/fda/5010576779703374844,hasRecallType,Class I
http://example.org/fda/822065451995172525,hasRecallType,Class II
http://example.org/fda/5062196777165891174,hasRecallReason,Sub-Potent Drug: Out of specification for assay at the 24 month interval.
http://example.org/fda/5465395455832276156,hasRecallType,Class II
http://example.org/fda/601280916201586996,hasRecallReason,CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
http://example.org/fda/2211206659671444938,hasRecallType,Class II
http://example.org/fda/5994813998653094599,hasRecallType,Class II
http://example.org/fda/1121034210945637569,hasRecallType,Class II
http://example.org/fda/179676865222124442,hasRecallReason,Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.
http://example.org/fda/181669137180219558,hasRecallType,Class I
http://example.org/fda/4346811005402660475,hasRecallType,Class II
http://example.org/fda/6774284630670253980,hasRecallType,Class I
http://example.org/fda/7852960911973289513,hasRecallType,Class II
http://example.org/fda/5618535267015343564,hasRecallType,Class II
http://example.org/fda/8912586762256390053,hasRecallReason,CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
http://example.org/fda/207698867015919738,hasRecallReason,Lack of Assurance of Sterility; media fill failure at manufacturer
http://example.org/fda/2252633846410719100,hasRecallReason,CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.
http://example.org/fda/798030487407568216,hasRecallReason,Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
http://example.org/fda/8462390381290478538,hasRecallType,Class II
http://example.org/fda/8514789466782407636,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/3609891063322169314,hasRecallType,Class II
http://example.org/fda/4244269446893543032,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/4576116828039010355,hasRecallReason,MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.
http://example.org/fda/6989254231324878005,hasRecallType,Class II
http://example.org/fda/7864807584530344732,hasRecallReason,Labeling: Incorrect or Missing Package Insert
http://example.org/fda/7695521103268253837,hasRecallReason,"Lack of Sterility Assurance: Microbial growth detected during a routine simulation of the manufacturing process, which represents the potential introduction of microorganisms into the products."
http://example.org/fda/9122297284803826350,hasRecallType,Class II
http://example.org/fda/3998226226470284508,hasRecallType,Class II
http://example.org/fda/5900744193658228783,hasRecallType,Class III
http://example.org/fda/5721082521137704356,hasRecallReason,Failed Impurities/Degradation Specifications: high out of specification results for Dexamethasone adduct (related compound).
http://example.org/fda/8201538308609663806,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/8550422134425190541,hasRecallReason,"Labeling: Label Mixup: LACTOBACILLUS ACIDOPHILUS, Tablet, 35 MILLION may have potentially been mislabeled as the following drug:  REPAGLINIDE, Tablet, 1 mg, NDC 00169008281, Pedigree: W003924, EXP: 6/28/2014."
http://example.org/fda/3848978960535033313,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/9128910374170605439,hasRecallType,Class II
http://example.org/fda/9012885002082907428,hasRecallType,Class II
http://example.org/fda/6820071363974839316,hasRecallType,Class II
http://example.org/fda/6942689762027432163,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/548898001590757248,hasRecallType,Class II
http://example.org/fda/8376932507743173970,hasRecallReason,CGMP Deviations: Firm went out of business and could no longer continue stability studies.
http://example.org/fda/8311842944573328195,hasRecallReason,Lack of Assurance of Sterility: There is the potential for the solution to leak from the seal of the fill tube to the bag.
http://example.org/fda/4025920211987324500,hasRecallType,Class II
http://example.org/fda/7774107049658344608,hasRecallType,Class II
http://example.org/fda/4760890197892112870,hasRecallReason,Lack of sterility assurance.
http://example.org/fda/5569038685815214013,hasRecallType,Class II
http://example.org/fda/4097529145070367316,hasRecallType,Class I
http://example.org/fda/8952123424139634772,hasRecallReason,CGMP Deviations: Firm went out of business and could no longer continue stability studies.
http://example.org/fda/5246518816596771665,hasRecallType,Class II
http://example.org/fda/8196733104177907812,hasRecallReason,"Marketed Without an Approved NDA/ANDA: product may contain undeclared sildenafil, tadalafil and analogues of these FDA approved active ingredients, making them unapproved drugs"
http://example.org/fda/2618641840314422808,hasRecallType,Class II
http://example.org/fda/3355456004593439874,hasRecallType,Class II
http://example.org/fda/7786460883981253678,hasRecallType,Class II
http://example.org/fda/8142661991236998631,hasRecallType,Class II
http://example.org/fda/3607866770069401457,hasRecallReason,Lack Of Assurance Of Sterility: Confirmed customer complaints of glass product container vials that may be broken or cracked.
http://example.org/fda/4525642031335618254,hasRecallReason,Microbial contamination
http://example.org/fda/4131843050274383058,hasRecallReason,Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
http://example.org/fda/4254649878222414558,hasRecallReason,Lack of Assurance of Sterility: Concerns with product sterility by the manufacturer of the eye wash irrigating solution.
http://example.org/fda/5007327090100214488,hasRecallType,Class II
http://example.org/fda/7844786567003378540,hasRecallReason,CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.
http://example.org/fda/1921637079920383958,hasRecallReason,cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
http://example.org/fda/1939894870249384041,hasRecallReason,CGMP Deviations
http://example.org/fda/5696566402554902947,hasRecallType,Class II
http://example.org/fda/3489812868828694491,hasRecallType,Class II
http://example.org/fda/8875823208839809553,hasRecallType,Class II
http://example.org/fda/6703769736985405058,hasRecallReason,CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
http://example.org/fda/1245406076056372403,hasRecallReason,CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.
http://example.org/fda/1486296305654765434,hasRecallReason,"Defective Delivery System: Out of Specification (OOS) results for the z-statistic value, which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration, were obtained."
http://example.org/fda/5494246804229704261,hasRecallReason,Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
http://example.org/fda/6856369821881458342,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/9081064596273475359,hasRecallReason,Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.
http://example.org/fda/5786190066212685328,hasRecallReason,Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
http://example.org/fda/5423949778936405437,hasRecallReason,Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
http://example.org/fda/4369076424171160455,hasRecallType,Class II
http://example.org/fda/6925059999631253681,hasRecallReason,"Labeling: Correct Labeled Product Miscart/Mispack: The shipper label displayed ""5 mL x 50,"" instead of ""10 mL x 50,"""
http://example.org/fda/216698950834597024,hasRecallType,Class II
http://example.org/fda/4218228935831673609,hasRecallReason,Microbial contamination
http://example.org/fda/2047585460255193717,hasRecallReason,Lack of Processing Controls.
http://example.org/fda/4170167411207141712,hasRecallReason,CGMP Deviations
http://example.org/fda/8435593086707952289,hasRecallReason,Lack of assurance of sterility: Lack of validation data for sanitization cycles
http://example.org/fda/3166772104302525452,hasRecallType,Class II
http://example.org/fda/8761053859546105293,hasRecallType,Class III
http://example.org/fda/7489342735899300993,hasRecallType,Class II
http://example.org/fda/219279194860127750,hasRecallReason,Impurities/Degradation Products: High Out of Specification results for a known impurity resulted at the 12-month room temperature time point.
http://example.org/fda/7617884418710164569,hasRecallType,Class I
http://example.org/fda/3860153084416413918,hasRecallType,Class III
http://example.org/fda/2047585460255193717,hasRecallType,Class II
http://example.org/fda/8174232672460765929,hasRecallReason,Lack of assurance of sterility: Lack of validation data for sanitization cycles
http://example.org/fda/6344935714792076254,hasRecallType,Class II
http://example.org/fda/4848588644563202597,hasRecallReason,"Marketed without an approved NDA/ANDA: presence of undeclared sibutramine, desmethylsibutramine (an active metabolite of sibutramine) and phenolphthalein."
http://example.org/fda/978074343469614274,hasRecallType,Class II
http://example.org/fda/3848978960535033313,hasRecallType,Class II
http://example.org/fda/2408084107977286333,hasRecallType,Class I
http://example.org/fda/2662087322914958556,hasRecallType,Class II
http://example.org/fda/5657611257221627394,hasRecallReason,CGMP Deviations: product held outside appropriate storage temperature conditions.
http://example.org/fda/7613468707050326929,hasRecallType,Class III
http://example.org/fda/6650164684303736014,hasRecallReason,Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
http://example.org/fda/5220700417589993684,hasRecallType,Class II
http://example.org/fda/1204053272162117707,hasRecallReason,Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
http://example.org/fda/8126651517536332120,hasRecallType,Class II
http://example.org/fda/2171944192554663996,hasRecallType,Class II
http://example.org/fda/1976633998701294501,hasRecallType,Class II
http://example.org/fda/597204405460573759,hasRecallReason,CGMP Deviations: FDA analysis found product to contain acetaldehyde above specification limits.
http://example.org/fda/5385648701018475899,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/454396351506308937,hasRecallType,Class II
http://example.org/fda/2550754045069763297,hasRecallReason,Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
http://example.org/fda/5494246804229704261,hasRecallType,Class II
http://example.org/fda/7353425449120722133,hasRecallReason,"Impurities/Degradation Products: The product was found to contain a slightly out of specification level of bromides, exceeding the bromides limit for USP Sodium Chloride."
http://example.org/fda/2240387985156564390,hasRecallType,Class II
http://example.org/fda/7365836569047675069,hasRecallType,Class II
http://example.org/fda/4733240281040240701,hasRecallReason,Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
http://example.org/fda/6298535418388525736,hasRecallReason,"Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves."
http://example.org/fda/5089471053606457807,hasRecallType,Class II
http://example.org/fda/6610733891885524320,hasRecallReason,"Presence of Particulate Matter: Certain batches of Atorvastatin tablets 10 mg, 20 mg and 40 mg may contain small glass particulates."
http://example.org/fda/3176207947426967671,hasRecallType,Class II
http://example.org/fda/7845783322590590279,hasRecallType,Class II
http://example.org/fda/5855788380455879197,hasRecallType,Class II
http://example.org/fda/5128625117207820061,hasRecallReason,Subpotent and Superpotent Drug. Out of specification assay results recorded as part of Uniformity of Container test during long-term stability testing.
http://example.org/fda/2115013303101624095,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/3998226226470284508,hasRecallReason,Lack of Processing Control
http://example.org/fda/4832983782025620510,hasRecallType,Class II
http://example.org/fda/5970643956067790465,hasRecallReason,"Labeling: Label Mixup: MINOCYCLINE HCL, Capsule, 100 mg may have potentially been mislabeled as the following drug:  PROGESTERONE, Capsule, 100 mg, NDC 00591396401, Pedigree: AD73611_4, EXP: 5/30/2014."
http://example.org/fda/4915135217151825180,hasRecallReason,"Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance."
http://example.org/fda/6142637192711171678,hasRecallType,Class II
http://example.org/fda/7010191538042121875,hasRecallType,Class II
http://example.org/fda/6027285311141684691,hasRecallReason,Cross contamination with other products: Certain lots of Fluocinonide Cream were found to be contaminated with a small quantity of hydrocortisone-17-valerate.
http://example.org/fda/6617486493720301872,hasRecallReason,Lack of Assurance of Sterility.
http://example.org/fda/6498143986517988148,hasRecallType,Class II
http://example.org/fda/1776851647173176362,hasRecallType,Class II
http://example.org/fda/4601122343221742857,hasRecallReason,Lack of Assurance of Sterility:  A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.
http://example.org/fda/526779259811209677,hasRecallReason,CGMP Deviations: products were stored outside the drug label specifications.
http://example.org/fda/4017699896438512588,hasRecallReason,CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
http://example.org/fda/678697884453403886,hasRecallReason,Microbial contamination
http://example.org/fda/1605384624851643993,hasRecallReason,Failed Tablet/Capsule Specifications
http://example.org/fda/5652288039196341971,hasRecallReason,Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specification.
http://example.org/fda/3550424355844471301,hasRecallReason,Presence of Foreign Tablets/Capsules: Firm received a market complaint stating the presence of one foreign tablet (Montelukast Sodium Chewable Tab 4mg) in the product bottle of Pantoprazole.
http://example.org/fda/4844153180812288449,hasRecallType,Class II
http://example.org/fda/1830341716058408055,hasRecallReason,"Labeling:Label Mixup; ZINC SULFATE Capsule, 220 mg may be potentially mislabeled as    CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: AD52778_10, EXP: 5/20/2014;  CALCITRIOL, Capsule, 0.25 mcg, NDC 00054000725, Pedigree: W003638, EXP: 6/25/2014."
http://example.org/fda/822065451995172525,hasRecallReason,Defective container: products are packaged in pouches which may not have been fully sealed
http://example.org/fda/1914942452132689877,hasRecallReason,Marketed without an Approved NDA/ANDA.
http://example.org/fda/3756325261639667478,hasRecallType,Class I
http://example.org/fda/6682384559030334160,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/2390849749745084705,hasRecallReason,"Presence of Foreign Substance; heavy metals (chromium, titanium etc) and inactive components of the product were visually observed during routine stability testing"
http://example.org/fda/4851856758084143460,hasRecallType,Class II
http://example.org/fda/7181186276996619374,hasRecallType,Class II
http://example.org/fda/1500757665592782720,hasRecallReason,Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.
http://example.org/fda/3185302239412791318,hasRecallType,Class III
http://example.org/fda/5127818400268238480,hasRecallReason,Marketed Without An Unapproved NDA/ANDA: All lots were found to be unapproved drugs based on labeling claims.
http://example.org/fda/6437993686049701439,hasRecallReason,Lack of assurance of sterility
http://example.org/fda/6815951840828990459,hasRecallType,Class III
http://example.org/fda/5923870180580026033,hasRecallType,Class I
http://example.org/fda/5543138663695722482,hasRecallType,Class II
http://example.org/fda/4499440969828641411,hasRecallType,Class II
http://example.org/fda/1790095540766048905,hasRecallType,Class II
http://example.org/fda/3947927082058403907,hasRecallReason,cGMP Deviations: Out of specification results for micro in hand soap products.
http://example.org/fda/1447847944616755419,hasRecallReason,CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
http://example.org/fda/8001244544286080181,hasRecallType,Class I
http://example.org/fda/5782451627514701206,hasRecallReason,Lack of sterility assurance.
http://example.org/fda/3378896524201809710,hasRecallReason,"Labeling: Label Mixup; FAMOTIDINE Tablet, 20 mg may be potentially mislabeled as    CARVEDILOL PHOSPHATE ER, Capsule, 20 mg, NDC 00007337113, Pedigree: W003225, EXP: 6/17/2014;  DULoxetine HCl DR, Capsule, 20 mg, NDC 00002323560, Pedigree: W003506, EXP: 6/21/2014;  FAMOTIDINE, Tablet, 20 mg, NDC 16714036104, Pedigree: W003507, EXP: 6/21/2014;  MYCOPHENOLATE MOFETIL, Capsule, 250 mg, NDC 0037822500"
http://example.org/fda/6895855202748201565,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/6220027198663437853,hasRecallType,Class III
http://example.org/fda/1897051234804533551,hasRecallType,Class II
http://example.org/fda/6656695986693765561,hasRecallReason,Superpotent Drug: Stability failure for assay at 6 months test time-point.
http://example.org/fda/6779045115039554637,hasRecallReason,CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.
http://example.org/fda/2187329978880623526,hasRecallType,Class II
http://example.org/fda/8659539876560996281,hasRecallType,Class II
http://example.org/fda/3683361109687816591,hasRecallReason,Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
http://example.org/fda/416104188364119155,hasRecallType,Class II
http://example.org/fda/4741555718588280467,hasRecallReason,Microbial contamination
http://example.org/fda/3791935339253921750,hasRecallType,Class III
http://example.org/fda/6656695986693765561,hasRecallType,Class II
http://example.org/fda/5234476663416912442,hasRecallType,Class II
http://example.org/fda/3060698260435226912,hasRecallType,Class II
http://example.org/fda/1584859512002090817,hasRecallReason,Lack of Assurance of Sterility: Concerns with product sterility by the manufacturer of the eye wash irrigating solution.
http://example.org/fda/5479232566060021295,hasRecallReason,Lack of Assurance of Sterility: Out of specification for volume and compromised container closure.
http://example.org/fda/6726906532897148136,hasRecallReason,Failed Dissolution Specification
http://example.org/fda/1112394949398489627,hasRecallReason,Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.
http://example.org/fda/198491292883963138,hasRecallType,Class II
http://example.org/fda/7592349378230711874,hasRecallReason,Lack Of Assurance Of Sterility.
http://example.org/fda/2146820948363689970,hasRecallType,Class I
http://example.org/fda/83030617995930616,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/5102565904391154117,hasRecallReason,Microbial contamination
http://example.org/fda/2578826859860512707,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/2421440890687676852,hasRecallType,Class II
http://example.org/fda/3160891244835805941,hasRecallType,Class II
http://example.org/fda/3695537247192808286,hasRecallType,Class I
http://example.org/fda/6590359796584267486,hasRecallType,Class II
http://example.org/fda/3202925646239676460,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/2138199202229148759,hasRecallType,Class III
http://example.org/fda/7767674099949636286,hasRecallReason,Lack of sterility assurance.
http://example.org/fda/1079589632980267272,hasRecallReason,Crystallization
http://example.org/fda/4717151341814130386,hasRecallType,Class II
http://example.org/fda/4155065152592579031,hasRecallReason,Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
http://example.org/fda/8600981381846112799,hasRecallReason,Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.
http://example.org/fda/814128516062705004,hasRecallReason,"Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall."
http://example.org/fda/8726605804167565122,hasRecallReason,Presence of Foreign Substance; metal particulates were visually observed in the tablets.
http://example.org/fda/8784547378574449330,hasRecallReason,Labeling; Incorrect or Missing Lot and/or Exp Date; some bottles labeled with lot number 05318054B instead of 05318034B
http://example.org/fda/3879450826944235769,hasRecallReason,Failed Stability Specifications
http://example.org/fda/6548002932721794013,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/2463390267725765545,hasRecallType,Class III
http://example.org/fda/5811982256078118373,hasRecallType,Class II
http://example.org/fda/7538170679404543489,hasRecallType,Class II
http://example.org/fda/2111500875826595784,hasRecallType,Class II
http://example.org/fda/2365812774855526817,hasRecallReason,CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
http://example.org/fda/2166196728077041198,hasRecallType,Class II
http://example.org/fda/3134639341739737510,hasRecallType,Class II
http://example.org/fda/6604203809375551043,hasRecallType,Class II
http://example.org/fda/8094415693636661494,hasRecallType,Class II
http://example.org/fda/1967115692604667357,hasRecallType,Class II
http://example.org/fda/4762575048112606615,hasRecallType,Class II
http://example.org/fda/1128433381310206855,hasRecallReason,"Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg"
http://example.org/fda/1914942452132689877,hasRecallType,Class II
http://example.org/fda/3511907476530417020,hasRecallType,Class II
http://example.org/fda/3695537247192808286,hasRecallReason,Failed Stability Specification and Failed Impurities/Degradation Specifications:  out of specification for inactive content ascorbic acid and MTHFRC-7impurity test
http://example.org/fda/3185302239412791318,hasRecallReason,FAILED CONTENT UNIFORMITY SPECIFICATIONS
http://example.org/fda/4086083399613251588,hasRecallReason,Failed Dissolution Specifications
http://example.org/fda/1662894131289718096,hasRecallReason,CGMP deviations- Lack of Quality Assurance
http://example.org/fda/5992946972335952784,hasRecallType,Class II
http://example.org/fda/6891016095519823735,hasRecallType,Class II
http://example.org/fda/6780732783606292246,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/9138474149610599268,hasRecallType,Class I
http://example.org/fda/3975569883174408744,hasRecallReason,Stability data does not support expiry.
http://example.org/fda/1640415051328168767,hasRecallReason,Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.
http://example.org/fda/2284783057344185,hasRecallType,Class II
http://example.org/fda/7380844040959250361,hasRecallType,Class II
http://example.org/fda/3720766819404400614,hasRecallReason,cGMP Deviations.
http://example.org/fda/8647596829105739892,hasRecallReason,Failed Impurities/Degradation Specifications: out of  specification test results for the norethindrone impurity.
http://example.org/fda/1969904906187256980,hasRecallType,Class II
http://example.org/fda/1356070627840597646,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/1396635294283147577,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/3009433468716297314,hasRecallType,Class II
http://example.org/fda/5672459586555024748,hasRecallType,Class I
http://example.org/fda/7151347861633822814,hasRecallType,Class II
http://example.org/fda/4342343230238281583,hasRecallType,Class II
http://example.org/fda/7845783322590590279,hasRecallReason,cGMP deviations
http://example.org/fda/5417664679205241391,hasRecallReason,Microbial contamination
http://example.org/fda/7187666116717432308,hasRecallReason,"Sun Pharmaceutical is recalling Azelastine HCl Nasal Solution, 0.1% (30 mL Bottle) following a failure to meet the % RSD requirement in the test for Droplet Size during the 6 month long term stability test station"
http://example.org/fda/7395879652974158428,hasRecallReason,Lack of Assurance of Sterility; product has the potential to leak.
http://example.org/fda/4502163736600315106,hasRecallReason,Lack of Processing Controls
http://example.org/fda/4318404211497386751,hasRecallReason,Failed Impurities/Degradation Specifications: Out of specification for impurities.
http://example.org/fda/1206085704577584235,hasRecallReason,cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
http://example.org/fda/3931842155487905604,hasRecallType,Class II
http://example.org/fda/5456037845297307013,hasRecallType,Class II
http://example.org/fda/4469176464341034190,hasRecallReason,cGMP deviations: due to shipment of rejected units.
http://example.org/fda/1319932464411040860,hasRecallType,Class III
http://example.org/fda/144723653439079097,hasRecallReason,Microbial contamination
http://example.org/fda/7480486652863892338,hasRecallReason,"Labeling Not Elsewhere Classified: front labels have the incorrect NDC or 0145-1506-01 instead of the correct NDC of 0145-1506-05 and some back labels have the incorrect indication stating ""use for the cure of most jock itch"" rather than ""use for the cure of most athlete's foot""."
http://example.org/fda/3505620858739787051,hasRecallType,Class II
http://example.org/fda/9154079486449725307,hasRecallReason,Microbial contamination
http://example.org/fda/8584380166926631222,hasRecallReason,Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.
http://example.org/fda/2367167435540020125,hasRecallReason,Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
http://example.org/fda/8923600166006653477,hasRecallReason,Lack of assurance of sterility
http://example.org/fda/7195649527623796544,hasRecallType,Class II
http://example.org/fda/6070568976331964791,hasRecallType,Class II
http://example.org/fda/1232659104039000094,hasRecallReason,Lack of assurance of sterility
http://example.org/fda/2668989100540572825,hasRecallReason,CGMP Deviations: Firm went out of business and could no longer continue stability studies.
http://example.org/fda/2820265205593836324,hasRecallReason,Lack of assurance of sterility
http://example.org/fda/6485991236421482748,hasRecallType,Class II
http://example.org/fda/4726524195710549224,hasRecallType,Class III
http://example.org/fda/2179026525996657757,hasRecallType,Class III
http://example.org/fda/213916844099382172,hasRecallReason,Microbial Contamination of Non Sterile Product; presence of yeast and potential B. cepacia contamination
http://example.org/fda/5173736741571515042,hasRecallType,Class III
http://example.org/fda/8574885084606672772,hasRecallType,Class II
http://example.org/fda/3292556835417591229,hasRecallReason,Microbial contamination
http://example.org/fda/1172494217521998917,hasRecallType,Class II
http://example.org/fda/694549865638933056,hasRecallReason,Failed Impurities/Degradation Specifications: A stability lot was out of specification for a known impurity at the 8 month Controlled Room Temperature stability time-point.
http://example.org/fda/8477653267908515993,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/9191035353714359939,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/3787001343421867089,hasRecallReason,CGMP Deviations: Intermittent exposure to temperature excursion during storage.
http://example.org/fda/3168254570326074609,hasRecallType,Class II
http://example.org/fda/7395120316719566126,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/9026848041933058549,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/103915713868924780,hasRecallType,Class II
http://example.org/fda/660513952962568350,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/4374321441451481748,hasRecallReason,Labeling; Label Mix-up; 4.25% DEXTROSE bag was found inside a 1.5% DEXTROSE box.
http://example.org/fda/2408084107977286333,hasRecallReason,Microbial contamination
http://example.org/fda/2262814547967842146,hasRecallType,Class II
http://example.org/fda/7489342735899300993,hasRecallReason,"CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit."
http://example.org/fda/8925976648757933676,hasRecallReason,Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
http://example.org/fda/1157758995313714041,hasRecallReason,Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
http://example.org/fda/4215782744992548530,hasRecallReason,Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
http://example.org/fda/8911855202833566284,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/4097529145070367316,hasRecallReason,Microbial contamination
http://example.org/fda/1977871880864803465,hasRecallType,Class II
http://example.org/fda/367732347997371290,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/341398405442701513,hasRecallReason,Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
http://example.org/fda/955339659132797166,hasRecallType,Class III
http://example.org/fda/8412183792131469114,hasRecallReason,Failed Impurities/Degradation Specifications: An out-of-specification result in the related substance test during three month long-term stability study.
http://example.org/fda/5930791637488660716,hasRecallReason,CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
http://example.org/fda/3051435568889263899,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/6507497283764887805,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/3553778648603917013,hasRecallType,Class II
http://example.org/fda/1128433381310206855,hasRecallType,Class II
http://example.org/fda/4848588644563202597,hasRecallType,Class I
http://example.org/fda/3070072058419991737,hasRecallReason,Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
http://example.org/fda/3504142143160994634,hasRecallReason,Lack of Assurance of Sterility: Potential leakage of bags.
http://example.org/fda/8684195402458718401,hasRecallType,Class II
http://example.org/fda/2798856790562113068,hasRecallType,Class II
http://example.org/fda/7649651296643174304,hasRecallReason,Failed Impurities/Degradation Specifications:OOS for unknown impurity.
http://example.org/fda/5658273276313147635,hasRecallReason,An error occurred where the product was manufactured with Potassium Chloride instead of Potassium Phosphate.
http://example.org/fda/4915135217151825180,hasRecallType,Class II
http://example.org/fda/1500757665592782720,hasRecallType,Class II
http://example.org/fda/6477651893248341312,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/2861658757770858395,hasRecallType,Class II
http://example.org/fda/7622867679896580283,hasRecallType,Class II
http://example.org/fda/51086985408065330,hasRecallReason,Microbial contamination
http://example.org/fda/2284783057344185,hasRecallReason,CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs
http://example.org/fda/3666104987526979386,hasRecallType,Class II
http://example.org/fda/2150566307569001448,hasRecallType,Class II
http://example.org/fda/6752953146064825680,hasRecallType,Class II
http://example.org/fda/1375692992969000735,hasRecallReason,"Microbial Contamination of Non-Sterile Products: FDA laboratory analysis found product to be contaminated with various microorganisms including Enterobacter cloacae, Cronobacter sakazakii, Cronobacter dublinensis, among others."
http://example.org/fda/1712149109145247206,hasRecallType,Class II
http://example.org/fda/3134639341739737510,hasRecallReason,"Labeling:Label Mixup; METOPROLOL TARTRATE, Tablet, 12.5 mg (1/2 of 25 mg) may be potentially mislabeled as    PIOGLITAZONE, Tablet, 15 mg, NDC 00591320530, Pedigree: AD22845_1, EXP: 4/30/2014;  LEVOTHYROXINE SODIUM, Tablet, 12.5 mcg (1/2 of 25 mcg), NDC 00527134101, Pedigree: AD73525_49, EXP: 5/30/2014."
http://example.org/fda/4970090721663817234,hasRecallType,Class II
http://example.org/fda/66360009186297031,hasRecallType,Class I
http://example.org/fda/3587486688956833210,hasRecallType,Class II
http://example.org/fda/4587743227847873093,hasRecallType,Class I
http://example.org/fda/6710458307588433985,hasRecallType,Class II
http://example.org/fda/1790095540766048905,hasRecallReason,Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that the product sterility may be compromised.
http://example.org/fda/7411640827213560775,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/5173736741571515042,hasRecallReason,Failed Impurities/Degradation Specifications; out of specification result for denitroquinoline-related impurity during three month time point
http://example.org/fda/3144607871300739461,hasRecallType,Class I
http://example.org/fda/418929400566429379,hasRecallReason,Lack of Processing Controls.
http://example.org/fda/2589585735257093193,hasRecallReason,CGMP Deviations
http://example.org/fda/7463831124132784153,hasRecallType,Class III
http://example.org/fda/3984775511222877602,hasRecallType,Class II
http://example.org/fda/2466486231086950428,hasRecallType,Class II
http://example.org/fda/8921121887376527129,hasRecallType,Class II
http://example.org/fda/4832983782025620510,hasRecallReason,CGMP Deviations: Intermittent exposure to temperature excursion during storage.
http://example.org/fda/8644503523443224197,hasRecallReason,Lack of Processing Controls.
http://example.org/fda/932893144448276626,hasRecallType,Class II
http://example.org/fda/3292010419214146011,hasRecallType,Class II
http://example.org/fda/5412940737425986246,hasRecallReason,Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
http://example.org/fda/4478838821625586106,hasRecallType,Class III
http://example.org/fda/9026848041933058549,hasRecallType,Class II
http://example.org/fda/8644503523443224197,hasRecallType,Class II
http://example.org/fda/7318042214208798068,hasRecallReason,Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.
http://example.org/fda/7695521103268253837,hasRecallType,Class II
http://example.org/fda/6915699957444766852,hasRecallType,Class II
http://example.org/fda/2799581312305715741,hasRecallReason,"Labeling: Label Mixup: NABUMETONE, Tablet, 500 mg may have potentially been mislabeled as the following drug:  guaiFENesin ER, Tablet, 600 mg, NDC 63824000834, Pedigree: AD46429_1, EXP: 5/15/2014."
http://example.org/fda/7994568319266834322,hasRecallType,Class II
http://example.org/fda/6647076918072562880,hasRecallType,Class II
http://example.org/fda/5829207240328864854,hasRecallReason,Failed Dissolution Specifications
http://example.org/fda/2680148456300641297,hasRecallType,Class II
http://example.org/fda/3538725621261110904,hasRecallReason,Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
http://example.org/fda/6219776552541948343,hasRecallReason,GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.
http://example.org/fda/4868593575639021811,hasRecallReason,Microbial contamination
http://example.org/fda/2984207272397948968,hasRecallReason,Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
http://example.org/fda/3104292743355712900,hasRecallType,Class II
http://example.org/fda/5992946972335952784,hasRecallReason,Lack of Assurance of Sterility.
http://example.org/fda/6554220910642003934,hasRecallType,Class II
http://example.org/fda/8412183792131469114,hasRecallType,Class III
http://example.org/fda/5696610804951808665,hasRecallReason,Failed Dissolution Specifications: The product did not meet the acceptance criteria for the dissolution test during the 24 month routine stability testing.
http://example.org/fda/221318596039464384,hasRecallType,Class II
http://example.org/fda/4533063859408315425,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/4666483827605170431,hasRecallReason,Labeling: Not Elsewhere Classified
http://example.org/fda/2912928930397201981,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/4587743227847873093,hasRecallReason,"Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sibutramine, a previously approved drug that was withdrawn from the US market due to safety concerns."
http://example.org/fda/6257839735034750469,hasRecallType,Class II
http://example.org/fda/8130262607902054935,hasRecallReason,"Labeling: Label Mixup:MINOXIDIL, Tablet, 2.5 mg may have potentially been mislabeled as the following drug:  methylPREDNISolone, Tablet, 4 mg, NDC 00781502201, Pedigree: AD52778_43, EXP: 5/20/2014."
http://example.org/fda/7358560234442454392,hasRecallType,Class III
http://example.org/fda/8988147719620079138,hasRecallReason,Labeling: Product Contains Undeclared API; Incorrect formulation
http://example.org/fda/7175616899475961061,hasRecallReason,Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.
http://example.org/fda/5207682165290960185,hasRecallReason,CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
http://example.org/fda/2680148456300641297,hasRecallReason,Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
http://example.org/fda/4086083399613251588,hasRecallType,Class II
http://example.org/fda/8656745747920022999,hasRecallType,Class II
http://example.org/fda/7874968880731509576,hasRecallReason,Superpotent Drug
http://example.org/fda/7975416540368056534,hasRecallReason,Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.
http://example.org/fda/8196733104177907812,hasRecallType,Class I
http://example.org/fda/5234476663416912442,hasRecallReason,CGMP Deviations: Nitrosamine Drug Substance Related Issue impurity above the daily acceptable intake limit defined by the Food and Drug Administration.
http://example.org/fda/1818728301497308087,hasRecallType,Class II
http://example.org/fda/33746005393324362,hasRecallType,Class III
http://example.org/fda/7850115000010482902,hasRecallType,Class III
http://example.org/fda/630692365754774181,hasRecallReason,"Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance."
http://example.org/fda/776057029063811243,hasRecallReason,CGMP Deviations: an expired active ingredient was used in the manufacture of these recalled lots.
http://example.org/fda/6355717142212364473,hasRecallReason,Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.
http://example.org/fda/2220534005407539014,hasRecallType,Class II
http://example.org/fda/110952495759581795,hasRecallType,Class II
http://example.org/fda/6380879745559320981,hasRecallReason,Failed Dissolution Specifications: Stability results found the product did not meet the drug release dissolution specifications.
http://example.org/fda/219164577916520289,hasRecallType,Class II
http://example.org/fda/9207793780382177016,hasRecallType,Class II
http://example.org/fda/4293490703889273532,hasRecallType,Class II
http://example.org/fda/3984775511222877602,hasRecallReason,Presence of Particulate; red and black particulate within the solution and embedded within the plastic vial identified as iron oxide
http://example.org/fda/8633674674474736654,hasRecallReason,"Non-Sterility: Green Valley Drugs received positive sterility results from their testing lab on two lots of Methylprednisolone Preservative Free 40 mg/mL injectable suspension and  one lot of Cyanocobalamin 1000 mcg/mL injection, 30 mL MDV."
http://example.org/fda/404888199326523759,hasRecallReason,"Labeling: Label Mix-up; The bottle of over-the-counter Acetaminophen 500mg Extra Strength, 100 count, included in Health Essential Kits, labeled incorrectly with a prescription drug label instead of an OTC drug label."
http://example.org/fda/1443472022932438261,hasRecallReason,CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.
http://example.org/fda/57642247718666106,hasRecallType,Class II
http://example.org/fda/8602488976472629784,hasRecallReason,Marketed Without An Approved NDA/ANDA: Product is being recalled due to excessive levels of lovastatin. Lovastatin is an FDA approved drug making this dietary supplement an unapproved new drug.
http://example.org/fda/4494449904627573605,hasRecallType,Class II
http://example.org/fda/1660572470462120809,hasRecallType,Class II
http://example.org/fda/963913935604993440,hasRecallType,Class II
http://example.org/fda/8249937228450435289,hasRecallReason,The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
http://example.org/fda/4744804525383498128,hasRecallType,Class II
http://example.org/fda/6123860992453410513,hasRecallType,Class II
http://example.org/fda/3916088784823844193,hasRecallType,Class II
http://example.org/fda/7175616899475961061,hasRecallType,Class II
http://example.org/fda/6484594729071229774,hasRecallType,Class II
http://example.org/fda/7926081000775741449,hasRecallReason,Lack of Assurance of Sterility: There are also CGMP Deviations.
http://example.org/fda/7945090591874624798,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/6085816991586163718,hasRecallReason,Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
http://example.org/fda/1037904823850250812,hasRecallType,Class I
http://example.org/fda/5902295057588828394,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/2774179521716024027,hasRecallType,Class I
http://example.org/fda/2513186892123918753,hasRecallType,Class II
http://example.org/fda/6554220910642003934,hasRecallReason,CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.
http://example.org/fda/7524268140387362390,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/8434287829230737383,hasRecallType,Class II
http://example.org/fda/3130222742580391108,hasRecallType,Class II
http://example.org/fda/7471073216436811476,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/7093880530978191192,hasRecallType,Class I
http://example.org/fda/2138199202229148759,hasRecallReason,Defective Container: Repetitive complaints received indicating pump not working.
http://example.org/fda/4961691475717183597,hasRecallType,Class II
http://example.org/fda/5979752129384826765,hasRecallType,Class III
http://example.org/fda/76308304491528493,hasRecallReason,Does Not Deliver Proper Metered Dose: Potential content of albuterol per dose is below specification.
http://example.org/fda/3587486688956833210,hasRecallReason,cGMP deviations
http://example.org/fda/2471728450546587796,hasRecallType,Class II
http://example.org/fda/465356910860324787,hasRecallReason,CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
http://example.org/fda/5223673382965262546,hasRecallType,Class II
http://example.org/fda/5981827750348432717,hasRecallType,Class II
http://example.org/fda/2418288982795059167,hasRecallType,Class I
http://example.org/fda/3023518649065572758,hasRecallReason,Failed Impurities/Degradation Specifications: Out of specification for impurities.
http://example.org/fda/5950012287356101220,hasRecallReason,"Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall."
http://example.org/fda/3876268022333042201,hasRecallType,Class II
http://example.org/fda/4175415675100594567,hasRecallType,Class II
http://example.org/fda/6663646028290445678,hasRecallType,Class III
http://example.org/fda/6681525051309194154,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/5210319473007162210,hasRecallReason,Lack of assurance of sterility: Lack of validation data for sanitization cycles
http://example.org/fda/8574885084606672772,hasRecallReason,Microbial Contamination of Non-Sterile Products
http://example.org/fda/8789060004081577930,hasRecallReason,CGMP Deviations
http://example.org/fda/6681525051309194154,hasRecallType,Class II
http://example.org/fda/2520505044943007248,hasRecallReason,"Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes."
http://example.org/fda/1723451817026207674,hasRecallType,Class III
http://example.org/fda/4926878072023357117,hasRecallReason,Crystallization: Recall is due to a non-characteristic gritty/sandy texture to the product which is likely due to some crystallization of the product.
http://example.org/fda/808820976677340677,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/2378675205373916965,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/1672348159638694171,hasRecallType,Class II
http://example.org/fda/6588861420967839106,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/7733637645331361270,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/190620534637121135,hasRecallReason,Lack of Assurance of Sterility.
http://example.org/fda/655325061961036829,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/5565693097234589125,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/5053325414945285651,hasRecallReason,Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots
http://example.org/fda/4346811005402660475,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/6804026157138322436,hasRecallType,Class II
http://example.org/fda/2604408822254990765,hasRecallReason,Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
http://example.org/fda/8684195402458718401,hasRecallReason,Failed Impurities/Degradation Specifications: High Out Of Specification degradation results.
http://example.org/fda/255089739141511114,hasRecallReason,Presence of Foreign Substance: raw material recalled due to stainless steel and other contamination.
http://example.org/fda/8997984818338914752,hasRecallReason,Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.
http://example.org/fda/96299001398741080,hasRecallType,Class II
http://example.org/fda/702295045451047162,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/8434287829230737383,hasRecallReason,Lack of Processing Controls.
http://example.org/fda/7805890844669741538,hasRecallType,Class II
http://example.org/fda/2303527139057175559,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/384081700434397511,hasRecallType,Class I
http://example.org/fda/2273677172561869419,hasRecallType,Class II
http://example.org/fda/702295045451047162,hasRecallType,Class II
http://example.org/fda/6561490618600331028,hasRecallReason,"Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin"
http://example.org/fda/8098353610739422367,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/96299001398741080,hasRecallReason,Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
http://example.org/fda/2741100406574262343,hasRecallReason,Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.
http://example.org/fda/8633674674474736654,hasRecallType,Class I
http://example.org/fda/8079525963798729736,hasRecallReason,"Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different products sold individually or as part of multi-unit kits in accordance with Consent Decree of Permanent Injunction ordered by the United States District Court due to misbranding and unapproved new drugs pursuant to the FD&C Act."
http://example.org/fda/7002005065341049048,hasRecallType,Class III
http://example.org/fda/7584218321069905722,hasRecallType,Class II
http://example.org/fda/1206085704577584235,hasRecallType,Class II
http://example.org/fda/3720766819404400614,hasRecallType,Class II
http://example.org/fda/6072312473414204695,hasRecallReason,Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
http://example.org/fda/7774107049658344608,hasRecallReason,CGMP Deviations: product held outside appropriate storage temperature conditions.
http://example.org/fda/1272650815514195936,hasRecallType,Class II
http://example.org/fda/5512224436346802251,hasRecallReason,Failed Impurities/Degradation Specifications: out of specification results for impurities/degradation testing for N-Oxide
http://example.org/fda/7402034824164743040,hasRecallReason,Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility.
http://example.org/fda/5037510865366524504,hasRecallType,Class II
http://example.org/fda/219164577916520289,hasRecallReason,The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
http://example.org/fda/867872190452043510,hasRecallReason,CGMP Deviations: product held outside appropriate storage temperature conditions.
http://example.org/fda/1277625452476818102,hasRecallType,Class I
http://example.org/fda/3819959402594443542,hasRecallType,Class II
http://example.org/fda/630692365754774181,hasRecallType,Class II
http://example.org/fda/1475393452617802729,hasRecallReason,Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.
http://example.org/fda/7893163290718960111,hasRecallReason,Stability Data Does Not Support Expiry
http://example.org/fda/1825619882210364454,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/5632550269913311997,hasRecallType,Class II
http://example.org/fda/6404191336835230191,hasRecallType,Class I
http://example.org/fda/3550424355844471301,hasRecallType,Class II
http://example.org/fda/5666669798667484646,hasRecallType,Class II
http://example.org/fda/7552117853905955634,hasRecallType,Class II
http://example.org/fda/1825619882210364454,hasRecallType,Class II
http://example.org/fda/5152088132319480937,hasRecallReason,"Labeling: Label Mixup; NIFEDIPINE Capsule, 10 mg may be potentially mislabeled as     MULTIVITAMIN/MULTIMINERAL W/FLUORIDE, Chew Tablet, 1 mg (F), NDC 64376081501, Pedigree: AD22609_7, EXP: 5/2/2014;  NIFEDIPINE, Capsule, 10 mg, NDC 43386044024, Pedigree: AD23082_7, EXP: 9/23/2013."
http://example.org/fda/3596548952960612396,hasRecallType,Class II
http://example.org/fda/6588861420967839106,hasRecallType,Class II
http://example.org/fda/5479232566060021295,hasRecallType,Class II
http://example.org/fda/6768837804852047112,hasRecallReason,Failed Impurities/Degradation Specifications
http://example.org/fda/8238472523840397367,hasRecallType,Class II
http://example.org/fda/9128910374170605439,hasRecallReason,Lack of sterility assurance
http://example.org/fda/1314468477279680824,hasRecallReason,"Paddock Laboratories, LLC are recalling one lot   (2012028142) of Moexipril HCl Tablets 7.5mg (expiration 1/2014) because of a  non-conformity dissolution failure result found during routine stability testing at the 6 month test interval."
http://example.org/fda/1681901192266718260,hasRecallReason,Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
http://example.org/fda/3210046755733514833,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/7079629904659284886,hasRecallType,Class II
http://example.org/fda/7592349378230711874,hasRecallType,Class II
http://example.org/fda/8218485386282252009,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/1971520662788227984,hasRecallType,Class II
http://example.org/fda/7898922859350630757,hasRecallType,Class III
http://example.org/fda/2658449483295846514,hasRecallType,Class II
http://example.org/fda/3111877544215018650,hasRecallType,Class II
http://example.org/fda/6594291594566370481,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/4701698022059088733,hasRecallReason,"Labeling: Label Mixup: TRI-BUFFERED ASPIRIN, Tablet, 325 mg may have potentially been mislabeled as the following drug:  ISOMETHEPTENE MUCATE/ DICHLORALPHENAZONE/APAP, Capsule, 65 mg/100 mg/325 mg, NDC 44183044001, Pedigree: W003596, EXP: 5/31/2014."
http://example.org/fda/4216340970571680203,hasRecallReason,FAILED DISSOLUTION SPECIFICATIONS
http://example.org/fda/5861470992137626602,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/8672548745410197563,hasRecallType,Class I
http://example.org/fda/7739252233620817028,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/4304938930654646794,hasRecallReason,Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
http://example.org/fda/2145718339072524723,hasRecallType,Class II
http://example.org/fda/4970090721663817234,hasRecallReason,"Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products."
http://example.org/fda/666342373472663903,hasRecallReason,Microbial contamination
http://example.org/fda/5757572310430335660,hasRecallType,Class II
http://example.org/fda/2889474973979051573,hasRecallType,Class II
http://example.org/fda/6891016095519823735,hasRecallReason,cGMP Deviations: lack of quality assurance at the API manufacturer.
http://example.org/fda/9106876328622668730,hasRecallType,Class II
http://example.org/fda/1681901192266718260,hasRecallType,Class II
http://example.org/fda/3607866770069401457,hasRecallType,Class II
http://example.org/fda/1820298520814061655,hasRecallType,Class II
http://example.org/fda/1978923297206119444,hasRecallType,Class I
http://example.org/fda/5220700417589993684,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/6257839735034750469,hasRecallReason,Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
http://example.org/fda/5053325414945285651,hasRecallType,Class III
http://example.org/fda/5898399150036708394,hasRecallReason,Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
http://example.org/fda/3483813734279583460,hasRecallReason,CGMP Deviations: Use of non-food grade lubricant in mixing vessel.
http://example.org/fda/6632254654122552851,hasRecallType,Class II
http://example.org/fda/7337733855620927115,hasRecallType,Class II
http://example.org/fda/5246518816596771665,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/5829207240328864854,hasRecallType,Class II
http://example.org/fda/3337889018660385238,hasRecallReason,Failed Impurities/Degradation Specifications
http://example.org/fda/8719443964613560659,hasRecallType,Class II
http://example.org/fda/8978848376465809181,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/7976455593311045907,hasRecallReason,Lack of Sterility Assurance.
http://example.org/fda/398713013471504612,hasRecallType,Class II
http://example.org/fda/8009407351813919406,hasRecallReason,CGMP Deviations:  lots and products of hand sanitizer are being recalled because they were manufactured under the same conditions as the product lot found to contain methanol.
http://example.org/fda/1251626105890658143,hasRecallType,Class II
http://example.org/fda/6204813206019224221,hasRecallType,Class II
http://example.org/fda/1939670474922426702,hasRecallReason,Lack of sterility assurance.
http://example.org/fda/6995190908853573836,hasRecallType,Class I
http://example.org/fda/1486296305654765434,hasRecallType,Class II
http://example.org/fda/865608484984024924,hasRecallReason,Lack of Processing Controls (lack of assurance of conformity to specifications).
http://example.org/fda/5975914469440740456,hasRecallType,Class II
http://example.org/fda/4359882723004269651,hasRecallReason,Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.
http://example.org/fda/7480486652863892338,hasRecallType,Class III
http://example.org/fda/684569185537998967,hasRecallType,Class II
http://example.org/fda/6674583111647009641,hasRecallType,Class II
http://example.org/fda/4478838821625586106,hasRecallReason,Labeling: Incorrect or missing lot and or Exp Date: The bottles were labeled with an incorrect expiry date 11/2016.  The correct expiry date is 09/2016.
http://example.org/fda/1771820347314741383,hasRecallReason,Superpotent Drug and Subpotent Drug: potency failures obtained
http://example.org/fda/2824307800266711098,hasRecallType,Class I
http://example.org/fda/2984207272397948968,hasRecallType,Class II
http://example.org/fda/8385887789433874617,hasRecallReason,Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
http://example.org/fda/5611410291934059589,hasRecallType,Class II
http://example.org/fda/4469176464341034190,hasRecallType,Class II
http://example.org/fda/3876268022333042201,hasRecallReason,CGMP Deviations: Intermittent exposure to temperature excursion during storage.
http://example.org/fda/7151230533610376950,hasRecallReason,CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.
http://example.org/fda/2645878299321922119,hasRecallReason,Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
http://example.org/fda/2587449852097695253,hasRecallReason,Lack of Assurance of Sterility:  A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.
http://example.org/fda/5672459586555024748,hasRecallReason,Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.
http://example.org/fda/4695809960034135553,hasRecallType,Class II
http://example.org/fda/6587240819303789574,hasRecallType,Class II
http://example.org/fda/4519752915123423028,hasRecallReason,CGMP Deviations
http://example.org/fda/7384192574707506022,hasRecallType,Class II
http://example.org/fda/3904107516312965404,hasRecallType,Class II
http://example.org/fda/3234473925676585424,hasRecallReason,Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
http://example.org/fda/7981858178983219092,hasRecallReason,CGMP Deviations: Firm did not adequately investigate customer complaints.
http://example.org/fda/848799193121106078,hasRecallType,Class II
http://example.org/fda/2662087322914958556,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/2252633846410719100,hasRecallType,Class III
http://example.org/fda/1862834053316787291,hasRecallReason,Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.
http://example.org/fda/2087459445908410549,hasRecallType,Class I
http://example.org/fda/5313615534925033782,hasRecallType,Class II
http://example.org/fda/354073496021671299,hasRecallType,Class II
http://example.org/fda/8997984818338914752,hasRecallType,Class II
http://example.org/fda/181669137180219558,hasRecallReason,Microbial contamination
http://example.org/fda/3759316319569653506,hasRecallType,Class I
http://example.org/fda/7465698963587542716,hasRecallType,Class II
http://example.org/fda/8151149890906561762,hasRecallType,Class II
http://example.org/fda/4015576655035492370,hasRecallReason,"Lack of Assurance of Sterility: preliminary environmental monitoring report exceeds limits, therefore sterility cannot be assured."
http://example.org/fda/615150850813001547,hasRecallType,Class II
http://example.org/fda/7695680700153184096,hasRecallType,Class II
http://example.org/fda/784411093478047629,hasRecallReason,Packaging defect: blister packaging inadequately sealed.
http://example.org/fda/1811674826730437845,hasRecallType,Class II
http://example.org/fda/3128885682495370555,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/5892559675301438459,hasRecallType,Class II
http://example.org/fda/2908127307755271887,hasRecallType,Class II
http://example.org/fda/1142813141352456533,hasRecallType,Class II
http://example.org/fda/4008302843810316438,hasRecallReason,CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
http://example.org/fda/5281144068125841438,hasRecallReason,Subpotent Drug: Flurandrenolide is subpotent.
http://example.org/fda/8273643561775248295,hasRecallReason,Failed impurities/degradation specifications: Purity readings for oxygen were out of specification.
http://example.org/fda/198491292883963138,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/3450213514466554403,hasRecallReason,Lack of Sterility Assurance.
http://example.org/fda/6068837586859108846,hasRecallReason,Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
http://example.org/fda/4147125082307404670,hasRecallType,Class II
http://example.org/fda/4666483827605170431,hasRecallType,Class III
http://example.org/fda/5696566402554902947,hasRecallReason,"Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance."
http://example.org/fda/6390140328665765837,hasRecallReason,CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
http://example.org/fda/4875810011603677538,hasRecallType,Class I
http://example.org/fda/8969930053822693516,hasRecallReason,Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
http://example.org/fda/8238472523840397367,hasRecallReason,The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
http://example.org/fda/4804309526329761421,hasRecallType,Class I
http://example.org/fda/8584380166926631222,hasRecallType,Class II
http://example.org/fda/2350899368413010206,hasRecallType,Class I
http://example.org/fda/1660572470462120809,hasRecallReason,Lack of assurance of sterility:
http://example.org/fda/341398405442701513,hasRecallType,Class II
http://example.org/fda/7500316074286683933,hasRecallType,Class II
http://example.org/fda/6460077287586100378,hasRecallType,Class I
http://example.org/fda/1875568148752541895,hasRecallType,Class II
http://example.org/fda/6202238176598944412,hasRecallReason,Penicillin Cross Contamination
http://example.org/fda/8462390381290478538,hasRecallReason,cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.
http://example.org/fda/3596548952960612396,hasRecallReason,Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
http://example.org/fda/2972075183889940338,hasRecallType,Class II
http://example.org/fda/6881746128778993052,hasRecallReason,Lack of sterility assurance.
http://example.org/fda/870307617136949255,hasRecallType,Class II
http://example.org/fda/6081002379342632351,hasRecallReason,"Labeling Incorrect Instructions:  This recall has been initiated because the Instructions for Use included in the Epi-Safe Kits for the Epi-Safe Syringe (and/or the Safety Lok Syringe in Model 8600-01120) recommend a midpoint dosage of epinephrine for children between 0 lbs. and 66 lbs. of 0.15mL that has not been approved by FDA for children. Reliance on the current IFU and/or use of the Epi-Safe Syringe as instructed may result in the administration of an inappropriate dosage of epinephrine to young children experiencing anaphylaxis, especially those under 33 lbs. Additionally the Epi Safe syringe does not have the correct markings to allow a health care provider to draw up the correct dosage for children under 33 kg."
http://example.org/fda/2721211413405153959,hasRecallType,Class II
http://example.org/fda/1897486392564975113,hasRecallType,Class I
http://example.org/fda/5040708705614820339,hasRecallReason,Superpotent (Multiple Ingredient) Drug: There is the potential for oversized and superpotent tablets.
http://example.org/fda/3659390904870772626,hasRecallReason,Microbial contamination
http://example.org/fda/7579662338017367939,hasRecallReason,Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
http://example.org/fda/1447847944616755419,hasRecallType,Class II
http://example.org/fda/2179026525996657757,hasRecallReason,Failed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point.
http://example.org/fda/2570782316828393775,hasRecallReason,Failed Impurities/Degradation Specifications: slightly elevated levels of phthalic acid.
http://example.org/fda/5755876587615066622,hasRecallReason,"CGMP Deviations: poor manufacturing practices resulted in Labeling: Incorrect or Missing Lot and/or Exp Date, product incorrectly labeled with incorrect lot and expiration date."
http://example.org/fda/1519005063430050576,hasRecallType,Class II
http://example.org/fda/6437993686049701439,hasRecallType,Class II
http://example.org/fda/1023978312407414319,hasRecallReason,"Labeling: Label Mixup: glyBURIDE MICRONIZED, Tablet, 3 mg may have potentially been mislabeled as the following drug:  DIGOXIN, Tablet, 0.125 mg, NDC 00115981101, Pedigree: W003154, EXP: 6/13/2014."
http://example.org/fda/9011284475972501580,hasRecallType,Class II
http://example.org/fda/4548303374376805620,hasRecallReason,Lack of Processing Controls.
http://example.org/fda/3306528213012220149,hasRecallReason,Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.
http://example.org/fda/1672348159638694171,hasRecallReason,"Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit"
http://example.org/fda/4345974743262200128,hasRecallType,Class II
http://example.org/fda/6181519712976965565,hasRecallType,Class II
http://example.org/fda/7438913159857266858,hasRecallType,Class II
http://example.org/fda/8946719827052792763,hasRecallType,Class II
http://example.org/fda/3166772104302525452,hasRecallReason,CGMP Deviations: Product was stored outside labeled storage temperature requirements. Product was exposed to controlled room temperature environment instead of remaining refrigerated.
http://example.org/fda/2585397172436601971,hasRecallType,Class II
http://example.org/fda/6421046544370814463,hasRecallReason,Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
http://example.org/fda/4187600106713579905,hasRecallType,Class I
http://example.org/fda/5930791637488660716,hasRecallType,Class II
http://example.org/fda/7617884418710164569,hasRecallReason,Microbial contamination
http://example.org/fda/3542734398608041525,hasRecallType,Class II
http://example.org/fda/7651084864701718490,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/5343501027616207810,hasRecallType,Class II
http://example.org/fda/1045597733887960152,hasRecallType,Class II
http://example.org/fda/1508457590502740341,hasRecallReason,"CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations."
http://example.org/fda/58162533981096283,hasRecallReason,"CGMP Deviation: Presence of NDEA (N-Nitrosodimethylamine), a carcinogen impurity, detected in the active ingredient."
http://example.org/fda/5976190877049613299,hasRecallType,Class II
http://example.org/fda/2240387985156564390,hasRecallReason,Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
http://example.org/fda/2971079734506505899,hasRecallType,Class II
http://example.org/fda/6663646028290445678,hasRecallReason,Failed Impurity/Degradation Specification; high out of specification result for 23 transacetyl impurity at the 22 month stability time point
http://example.org/fda/4215782744992548530,hasRecallType,Class II
http://example.org/fda/7917913277102164594,hasRecallType,Class II
http://example.org/fda/3850700804033629895,hasRecallType,Class II
http://example.org/fda/1236043666039942121,hasRecallType,Class II
http://example.org/fda/6942662919773165782,hasRecallType,Class III
http://example.org/fda/6815951840828990459,hasRecallReason,Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.
http://example.org/fda/3267497971674868587,hasRecallReason,"Subpotent Drug: Avobenzone 3%, one of the active sunscreen ingredients may be subpotent and sunscreen effectiveness may be less than labeled"
http://example.org/fda/6481975180585984341,hasRecallReason,CGMP Deviations: Products manufactured with an ingredient that exceed the benzene levels allowed in drug products.
http://example.org/fda/6739715503406538176,hasRecallType,Class II
http://example.org/fda/6081002379342632351,hasRecallType,Class II
http://example.org/fda/8880211010646448966,hasRecallType,Class I
http://example.org/fda/248158152011171121,hasRecallReason,"Marketed Without An Approved NDA/ANDA: This dietary supplement has been found to contain sildenafil, an FDA approved drug for the treatment of male erectile dysfunction making this an unapproved new drug."
http://example.org/fda/3160891244835805941,hasRecallReason,CGMP Deviations
http://example.org/fda/7366656642825551563,hasRecallType,Class II
http://example.org/fda/2708183172794967995,hasRecallReason,Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
http://example.org/fda/2658449483295846514,hasRecallReason,"CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product."
http://example.org/fda/2908127307755271887,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/7864807584530344732,hasRecallType,Class III
http://example.org/fda/5976190877049613299,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/1508457590502740341,hasRecallType,Class II
http://example.org/fda/2112507474873126220,hasRecallType,Class II
http://example.org/fda/2323567000396722020,hasRecallType,Class III
http://example.org/fda/2450501064749628684,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/8096994186035048767,hasRecallReason,Failed stability specifications - An out of specification result was observed for the test parameter : composition of Nystatin during stability testing.
http://example.org/fda/2262814547967842146,hasRecallReason,CGMP Deviations: product held outside appropriate storage temperature conditions.
http://example.org/fda/5543138663695722482,hasRecallReason,Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
http://example.org/fda/2450501064749628684,hasRecallType,Class II
http://example.org/fda/6466460185248198641,hasRecallType,Class II
http://example.org/fda/5674271140358429152,hasRecallType,Class II
http://example.org/fda/2463390267725765545,hasRecallReason,Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing
http://example.org/fda/2211206659671444938,hasRecallReason,Lack of Assurance of Sterility: A mold like substance was discovered on the surface of an unopened bag of Sodium Chloride 0.9% while prepping the bag for production.
http://example.org/fda/454396351506308937,hasRecallReason,Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
http://example.org/fda/5605912935943993728,hasRecallReason,CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.
http://example.org/fda/5706317052308509189,hasRecallType,Class II
http://example.org/fda/3609891063322169314,hasRecallReason,Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products
http://example.org/fda/6590359796584267486,hasRecallReason,CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
http://example.org/fda/4502163736600315106,hasRecallType,Class II
http://example.org/fda/4859326836639100431,hasRecallReason,Lack of sterility assurance
http://example.org/fda/5425169482696214973,hasRecallType,Class III
http://example.org/fda/7114421300658289619,hasRecallType,Class II
http://example.org/fda/961621477717987553,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/8918426301499513668,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/4910558732640097841,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/3256821052236207449,hasRecallReason,Subpotent Drug
http://example.org/fda/7819120239039670232,hasRecallType,Class I
http://example.org/fda/1157611713948682394,hasRecallReason,Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.
http://example.org/fda/1871343900020037406,hasRecallType,Class II
http://example.org/fda/3385816474500173282,hasRecallType,Class II
http://example.org/fda/1976633998701294501,hasRecallReason,"Labeling: Not Elsewhere Classified; Due to an error in the manufacturing procedure, a cylinder in liquid withdrawal service was not marked Syphon Tube indicating liquid withdrawal and shipped as a gas withdrawal cylinder."
http://example.org/fda/6604203809375551043,hasRecallReason,Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
http://example.org/fda/1640415051328168767,hasRecallType,Class II
http://example.org/fda/4398828639649045363,hasRecallReason,GMP Deviation; A foreign stopper was observed during packaging of a lot of product.
http://example.org/fda/144958799957545750,hasRecallReason,Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
http://example.org/fda/1827800446294855597,hasRecallType,Class II
http://example.org/fda/4244269446893543032,hasRecallType,Class II
http://example.org/fda/6460077287586100378,hasRecallReason,Marketed Without an Approved NDA/ANDA: FDA analysis found product to contain sibutramine and phenolphthalein
http://example.org/fda/2367167435540020125,hasRecallType,Class II
http://example.org/fda/6207215825000821222,hasRecallReason,Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
http://example.org/fda/1179963588127312615,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/3867545482205271616,hasRecallType,Class II
http://example.org/fda/9222906428059805922,hasRecallType,Class I
http://example.org/fda/6253449738224550884,hasRecallType,Class I
http://example.org/fda/3483813734279583460,hasRecallType,Class II
http://example.org/fda/4369076424171160455,hasRecallReason,Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
http://example.org/fda/798030487407568216,hasRecallType,Class I
http://example.org/fda/8009407351813919406,hasRecallType,Class II
http://example.org/fda/1174615022801221486,hasRecallReason,CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.
http://example.org/fda/2845753967457132962,hasRecallReason,cGMP Deviations
http://example.org/fda/7538170679404543489,hasRecallReason,"Labeling: Label Mixup: FLECAINIDE ACETATE, Tablet, 100 mg may be potentially mislabeled as the following drug:   COLESTIPOL HCL MICRONIZED, Tablet, 1 g, NDC 59762045001, Pedigree: AD56847_1, EXP: 5/21/2014."
http://example.org/fda/3210753272608970587,hasRecallType,Class III
http://example.org/fda/7217672023295826542,hasRecallType,Class II
http://example.org/fda/2891884722807724437,hasRecallReason,CGMP Deviations: Firm did not adequately investigate customer complaints.
http://example.org/fda/2694206862589082587,hasRecallType,Class II
http://example.org/fda/3306528213012220149,hasRecallType,Class II
http://example.org/fda/57642247718666106,hasRecallReason,Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
http://example.org/fda/119715835741213627,hasRecallReason,CGMP Deviations: Presence of NDMA impurity detected in product.
http://example.org/fda/7186999475051394869,hasRecallReason,Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
http://example.org/fda/7749554141085876186,hasRecallReason,CGMP Deviations: Intermittent exposure to temperature excursion during storage.
http://example.org/fda/5970643956067790465,hasRecallType,Class II
http://example.org/fda/7184603922938632485,hasRecallReason,cGMP Deviations
http://example.org/fda/1224308298099071637,hasRecallType,Class III
http://example.org/fda/3220566464553225985,hasRecallReason,CGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production.
http://example.org/fda/5791359471110924336,hasRecallReason,Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.
http://example.org/fda/8592258452443976296,hasRecallReason,CGMP Deviations: product held outside appropriate storage temperature conditions.
http://example.org/fda/2415290094488947825,hasRecallType,Class II
http://example.org/fda/4954023695438095648,hasRecallType,Class I
http://example.org/fda/1820298520814061655,hasRecallReason,Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.
http://example.org/fda/8919154840340465713,hasRecallType,Class II
http://example.org/fda/4375650157027340260,hasRecallType,Class II
http://example.org/fda/4018690629158556480,hasRecallType,Class II
http://example.org/fda/2188432617673755329,hasRecallType,Class I
http://example.org/fda/3385816474500173282,hasRecallReason,The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
http://example.org/fda/1662894131289718096,hasRecallType,Class II
http://example.org/fda/7613468707050326929,hasRecallReason,Failed Dissolution Specifications
http://example.org/fda/5782451627514701206,hasRecallType,Class II
http://example.org/fda/4093127647695093331,hasRecallReason,CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
http://example.org/fda/465356910860324787,hasRecallType,Class II
http://example.org/fda/4196780542329821226,hasRecallType,Class II
http://example.org/fda/5463466138591010752,hasRecallReason,Defective Container: Leaking containers.
http://example.org/fda/5177900552097081525,hasRecallReason,Marketed without an Approved NDA/ANDA; product labeled to contain 0.56% methanol making it an unapproved new drug
http://example.org/fda/76308304491528493,hasRecallType,Class II
http://example.org/fda/8478545332244712024,hasRecallReason,Lack of assurance of sterility: Lack of validation data for sanitization cycles
http://example.org/fda/8923600166006653477,hasRecallType,Class II
http://example.org/fda/786799191513177424,hasRecallReason,"GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product."
http://example.org/fda/8151484814589467336,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/1804800381222757155,hasRecallType,Class II
http://example.org/fda/2820265205593836324,hasRecallType,Class II
http://example.org/fda/4131843050274383058,hasRecallType,Class II
http://example.org/fda/5015203132137530886,hasRecallReason,CGMP Deviations:
http://example.org/fda/5706317052308509189,hasRecallReason,Temperature abuse: Certain vials of Ifosfamide IV products were not refrigerated at certain Amerisource Bergen Drug Corp distribution centers.
http://example.org/fda/3238216632870403251,hasRecallType,Class II
http://example.org/fda/2645878299321922119,hasRecallType,Class II
http://example.org/fda/33746005393324362,hasRecallReason,Failed Impurities/Degradation Specifications; out of specification for Related Compound
http://example.org/fda/3847654338540877244,hasRecallReason,Presence of Particulate Matter; product complaint of hair discovered in a vial within the lot
http://example.org/fda/5757572310430335660,hasRecallReason,"cGMP Deviations; during the production process, CLENZIderm M.D. Daily Foam Cleanser was filled into some bottles labeled as CLENZIderm M.D. Pore Therapy"
http://example.org/fda/7928631525664976303,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/7150800101904890030,hasRecallReason,CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.
http://example.org/fda/7463831124132784153,hasRecallReason,Labeling: Not Elsewhere Classified
http://example.org/fda/867872190452043510,hasRecallType,Class II
http://example.org/fda/5618535267015343564,hasRecallReason,Presence of Particular Matter: Potential glass delamination and consistent with glass particulates observed in sample vials.
http://example.org/fda/1299052528111628195,hasRecallType,Class I
http://example.org/fda/3161334286730679621,hasRecallType,Class II
http://example.org/fda/3446471927468073458,hasRecallReason,"Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes."
http://example.org/fda/527711001754493471,hasRecallType,Class II
http://example.org/fda/963913935604993440,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/6916240935412328329,hasRecallType,Class II
http://example.org/fda/1157611713948682394,hasRecallType,Class II
http://example.org/fda/4218228935831673609,hasRecallType,Class I
http://example.org/fda/147079419507402646,hasRecallReason,Microbial Contamination of Non-Sterile Product: Presence of Pseudomonas aeruginosa in product
http://example.org/fda/8374155116622959289,hasRecallType,Class II
http://example.org/fda/2966914026615335650,hasRecallType,Class I
http://example.org/fda/3486415720845499945,hasRecallReason,Superpotent Drug: recalled lots may have higher concentration of ibuprofen.
http://example.org/fda/9092921149638678407,hasRecallReason,Lack of Assurance of Sterility: The pharmacy is recalling one lot of Hydroxocobalamin MDV 5mg/mL due to failed sterility results by a third party contract testing lab. Hence the sterility of the product cannot be assured.
http://example.org/fda/8309216060679564868,hasRecallReason,Subpotent Drug: Stability data does not support the current expiration dating of 55 days after compounding.
http://example.org/fda/3602308182054441867,hasRecallReason,Failed Stability Specifications; out-of specification value for homogeneity / phase separation.
http://example.org/fda/2227476994621402652,hasRecallType,Class II
http://example.org/fda/3312745246094232764,hasRecallReason,Failed Dissolution Specifications; three month stability time point.
http://example.org/fda/4612132844597846209,hasRecallReason,Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.
http://example.org/fda/1028362029688879018,hasRecallType,Class I
http://example.org/fda/5620809164419447569,hasRecallType,Class II
http://example.org/fda/6872208455703033911,hasRecallType,Class I
http://example.org/fda/8494692318245838651,hasRecallType,Class II
http://example.org/fda/6324121879583560650,hasRecallType,Class II
http://example.org/fda/1561244364922988843,hasRecallType,Class II
http://example.org/fda/6449620314837304768,hasRecallType,Class II
http://example.org/fda/8784547378574449330,hasRecallType,Class III
http://example.org/fda/145233224761598598,hasRecallReason,cGMP Deviations
http://example.org/fda/7318042214208798068,hasRecallType,Class II
http://example.org/fda/231247494406237959,hasRecallType,Class II
http://example.org/fda/5658273276313147635,hasRecallType,Class III
http://example.org/fda/219279194860127750,hasRecallType,Class III
http://example.org/fda/4685663675194709031,hasRecallType,Class II
http://example.org/fda/1996045866837604011,hasRecallType,Class II
http://example.org/fda/4519752915123423028,hasRecallType,Class II
http://example.org/fda/5726868240992351708,hasRecallType,Class II
http://example.org/fda/4726524195710549224,hasRecallReason,Chemical Contamination: out of specification results for impurities were found to be the result of contamination of product from vapors associated with paint thinner used in repair of the manufacturing room.
http://example.org/fda/5975914469440740456,hasRecallReason,Lack of Assurance of Sterility: the manufacturing firm had microbial recoveries during environmental monitoring in aseptic areas of manufacturing.
http://example.org/fda/2464494917872510782,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/3102873805890494037,hasRecallReason,Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
http://example.org/fda/4525642031335618254,hasRecallType,Class I
http://example.org/fda/7716552703488206757,hasRecallReason,Presence of Particulate Matter: Crystalline particles were noticed by manufacturer at the 24 month clarity testing.
http://example.org/fda/6591725625998264168,hasRecallType,Class II
http://example.org/fda/4344357535919148593,hasRecallType,Class II
http://example.org/fda/6457283958782729097,hasRecallType,Class I
http://example.org/fda/2845753967457132962,hasRecallType,Class II
http://example.org/fda/2431059756439988228,hasRecallReason,Temperature Abuse
http://example.org/fda/4557493502924079406,hasRecallType,Class I
http://example.org/fda/9200830486754588992,hasRecallType,Class II
http://example.org/fda/6730607084477073492,hasRecallType,Class II
http://example.org/fda/6995190908853573836,hasRecallReason,"Marketed Without An Approved NDA/ANDA: The product contains undeclared sibutramine and phenolphthalein. Marketed Without An Approved NDA/ANDA: The product contains undeclared sibutramine and phenolphthalein. Sibutramine and phenolphthalein are not currently marketed in the United States, making this product an unapproved new drug."
http://example.org/fda/8548358030071668990,hasRecallReason,Lack of assurance of sterility:
http://example.org/fda/6722964123789133386,hasRecallReason,Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
http://example.org/fda/1768054811115445307,hasRecallType,Class II
http://example.org/fda/3511907476530417020,hasRecallReason,Presence of Particulate matter. Recall due to presence of unknown particulate matter.
http://example.org/fda/8724357199806671045,hasRecallType,Class II
http://example.org/fda/7889868166062486230,hasRecallType,Class II
http://example.org/fda/952546189032429376,hasRecallReason,"Microbial Contamination of Non-Sterile Product.Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, growth of Aspergillus penicillioides, a type of fungus, resulted in a breach of the package integrity."
http://example.org/fda/1492905594506216748,hasRecallReason,CGMP Deviations: product held outside appropriate storage temperature conditions.
http://example.org/fda/4196377834157244226,hasRecallType,Class II
http://example.org/fda/3856186205927465774,hasRecallType,Class II
http://example.org/fda/1443857192782330487,hasRecallType,Class II
http://example.org/fda/2987126102226857030,hasRecallReason,"Microbial Contamination of Non Sterile Products; Products contaminated with microoganisms, including but not limited to Staphylococcus saprophyticus and Burkholderia cepacia"
http://example.org/fda/5405211768256732780,hasRecallReason,Penicillin Cross Contamination: potentially contaminated with penicillin
http://example.org/fda/7217672023295826542,hasRecallReason,CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
http://example.org/fda/5638311776022982389,hasRecallType,Class II
http://example.org/fda/6058470966368382925,hasRecallType,Class II
http://example.org/fda/3882588970850523105,hasRecallReason,Failed Impurities/Degradation Specifications: failed impurities for Sulphoxide and Impurity A.
http://example.org/fda/5281144068125841438,hasRecallType,Class III
http://example.org/fda/7913856060397561225,hasRecallType,Class II
http://example.org/fda/1956654487315858252,hasRecallType,Class I
http://example.org/fda/651690536257417662,hasRecallType,Class II
http://example.org/fda/6202238176598944412,hasRecallType,Class II
http://example.org/fda/231247494406237959,hasRecallReason,The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
http://example.org/fda/2074380231606225639,hasRecallType,Class II
http://example.org/fda/5297499532472708739,hasRecallType,Class III
http://example.org/fda/4361845737108872835,hasRecallType,Class II
http://example.org/fda/3312745246094232764,hasRecallType,Class II
http://example.org/fda/1528684812105043862,hasRecallType,Class II
http://example.org/fda/807125466588240142,hasRecallType,Class II
http://example.org/fda/5528307156123729586,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/4741555718588280467,hasRecallType,Class I
http://example.org/fda/2187329978880623526,hasRecallReason,Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products
http://example.org/fda/718695925851371717,hasRecallType,Class II
http://example.org/fda/8514789466782407636,hasRecallType,Class II
http://example.org/fda/3542734398608041525,hasRecallReason,Lack of Assurance of Sterility: There are also CGMP Deviations.
http://example.org/fda/4405922135090031232,hasRecallReason,CGMP Deviations
http://example.org/fda/6028148081480805065,hasRecallReason,Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
http://example.org/fda/1753287250592091855,hasRecallType,Class II
http://example.org/fda/1845224832799557540,hasRecallType,Class II
http://example.org/fda/8988147719620079138,hasRecallType,Class III
http://example.org/fda/7235941287482762198,hasRecallType,Class II
http://example.org/fda/1249042915159075060,hasRecallReason,Lack of Assurance of Sterility: Sterility of product is not assured.
http://example.org/fda/179676865222124442,hasRecallType,Class II
http://example.org/fda/77044880742775769,hasRecallType,Class II
http://example.org/fda/5102565904391154117,hasRecallType,Class I
http://example.org/fda/3736690743238649517,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/6674583111647009641,hasRecallReason,CGMP deviations
http://example.org/fda/2395250721566481373,hasRecallType,Class III
http://example.org/fda/3267497971674868587,hasRecallType,Class III
http://example.org/fda/7926081000775741449,hasRecallType,Class II
http://example.org/fda/535500938967534586,hasRecallType,Class I
http://example.org/fda/6942689762027432163,hasRecallType,Class II
http://example.org/fda/932411233529475539,hasRecallReason,Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.
http://example.org/fda/7905768304453022604,hasRecallType,Class II
http://example.org/fda/2489972811354781569,hasRecallReason,CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
http://example.org/fda/5802790398249100682,hasRecallType,Class II
http://example.org/fda/3947927082058403907,hasRecallType,Class II
http://example.org/fda/7189870077174860209,hasRecallReason,cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
http://example.org/fda/5811982256078118373,hasRecallReason,Lack of sterility assurance.
http://example.org/fda/86570348399702649,hasRecallReason,Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.
http://example.org/fda/1157429423483586760,hasRecallType,Class II
http://example.org/fda/6288127283011466454,hasRecallReason,Non-Sterility
http://example.org/fda/2248421706548036,hasRecallType,Class II
http://example.org/fda/5381334668396065514,hasRecallType,Class II
http://example.org/fda/6220027198663437853,hasRecallReason,Failed Dissolution Specifications: Nitrofurantoin Capsules recalled due to dissolution failure at 0-time of the repackaged lot. Drug release results were above specification at 0-time.
http://example.org/fda/3486415720845499945,hasRecallType,Class II
http://example.org/fda/2023096200388967778,hasRecallReason,CGMP deviations- Lack of Quality Assurance
http://example.org/fda/1928468155405670886,hasRecallReason,Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit
http://example.org/fda/1201385077615987523,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/2600722204916718453,hasRecallReason,The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
http://example.org/fda/2889474973979051573,hasRecallReason,CGMP deviations
http://example.org/fda/150529202784823430,hasRecallReason,CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.
http://example.org/fda/1862834053316787291,hasRecallType,Class III
http://example.org/fda/4873357824879196798,hasRecallType,Class II
http://example.org/fda/4405402144467774050,hasRecallReason,Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.
http://example.org/fda/1028362029688879018,hasRecallReason,"Labeling: Label Mix-Up: Some cartons of AHP Ibuprofen Tablets, USP, 600mg, lot #142588 that contain blister cards filled with Ibuprofen tablets, 600mg drug product, were found to be mis-labeled  with blister card print identifying the product as AHP Oxcarbazepine Tablets, 300mg, lot #142544"
http://example.org/fda/145233224761598598,hasRecallType,Class II
http://example.org/fda/6925917211625221911,hasRecallType,Class I
http://example.org/fda/3378896524201809710,hasRecallType,Class II
http://example.org/fda/2578826859860512707,hasRecallType,Class II
http://example.org/fda/6288127283011466454,hasRecallType,Class I
http://example.org/fda/8510928336444912208,hasRecallReason,"Labeling -label error on declared strength: unopened, sealed bottle of Terazosin Hydrochloride (HCl) 10mg Capsules contained Terazosin HCl 5 mg Capsules"
http://example.org/fda/1121034210945637569,hasRecallReason,CGMP Deviations: Products not manufactured under current good manufacturing practices.
http://example.org/fda/8130262607902054935,hasRecallType,Class II
http://example.org/fda/1157758995313714041,hasRecallType,Class II
http://example.org/fda/6856369821881458342,hasRecallType,Class II
http://example.org/fda/7786460883981253678,hasRecallReason,Lack of Assurance of Sterility; container closure issues with the bulk batch.
http://example.org/fda/8912586762256390053,hasRecallType,Class II
http://example.org/fda/7114421300658289619,hasRecallReason,Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.
http://example.org/fda/1157429423483586760,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/1174615022801221486,hasRecallType,Class II
http://example.org/fda/407320578040319787,hasRecallType,Class I
http://example.org/fda/4245305720532755595,hasRecallReason,Subpotent Drug
http://example.org/fda/7980330501869601697,hasRecallType,Class II
http://example.org/fda/6710458307588433985,hasRecallReason,Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
http://example.org/fda/5892559675301438459,hasRecallReason,CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
http://example.org/fda/7162405059949436568,hasRecallType,Class II
http://example.org/fda/7905768304453022604,hasRecallReason,CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit
http://example.org/fda/3961392900059836966,hasRecallReason,Microbial contamination of non-sterile product.
http://example.org/fda/418929400566429379,hasRecallType,Class II
http://example.org/fda/9153031696169683805,hasRecallType,Class III
http://example.org/fda/4859326836639100431,hasRecallType,Class II
http://example.org/fda/6658360316564555471,hasRecallType,Class II
http://example.org/fda/868715377019234251,hasRecallType,Class II
http://example.org/fda/4147125082307404670,hasRecallReason,CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
http://example.org/fda/4175415675100594567,hasRecallReason,"Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance."
http://example.org/fda/6780050984056098725,hasRecallType,Class II
http://example.org/fda/8201538308609663806,hasRecallType,Class II
http://example.org/fda/8477653267908515993,hasRecallType,Class II
http://example.org/fda/8226254148337096749,hasRecallType,Class II
http://example.org/fda/7292430894180563394,hasRecallType,Class II
http://example.org/fda/6358868119992887589,hasRecallType,Class II
http://example.org/fda/660513952962568350,hasRecallType,Class II
http://example.org/fda/7911913443890490842,hasRecallType,Class II
http://example.org/fda/8934674337478009664,hasRecallReason,"Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different products sold individually or as part of multi-unit kits in accordance with Consent Decree of Permanent Injunction ordered by the United States District Court due to misbranding and unapproved new drugs pursuant to the FD&C Act."
http://example.org/fda/2513186892123918753,hasRecallReason,Failed Dissolution Specifications: Out-of-specification results for dissolution (above specification)
http://example.org/fda/8862034963755189664,hasRecallReason,"Labeling: Label Mixup: SILDENAFIL CITRATE, Tablet, 25 mg may have potentially been mislabeled as the following drug:  PHENobarbital/ HYOSCYAMINE/ ATROPINE/ SCOPOLAMINE, Tablet, 16.2 mg/0.1037 mg/0.0194 mg/0.0065 mg, NDC 66213042510, Pedigree: W003640, EXP: 6/25/2014."
http://example.org/fda/8911855202833566284,hasRecallType,Class II
http://example.org/fda/9154079486449725307,hasRecallType,Class I
http://example.org/fda/5385648701018475899,hasRecallType,Class II
http://example.org/fda/7437952646629275180,hasRecallReason,Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible.
http://example.org/fda/7195649527623796544,hasRecallReason,cGMP deviations: Temperature abuse
http://example.org/fda/551409117624238169,hasRecallReason,Lack of assurance of sterility: customer complaints received for the presence of leaks.
http://example.org/fda/7058022417693223705,hasRecallType,Class I
http://example.org/fda/5151907207797773605,hasRecallType,Class II
http://example.org/fda/6872208455703033911,hasRecallReason,Microbial contamination of Non-Sterile Products
http://example.org/fda/5481585765602254140,hasRecallReason,Subpotent Drug: FDA analysis has revealed some bottles of these products were sub potent for ethanol.
http://example.org/fda/4187600106713579905,hasRecallReason,"Marketed without an Approved NDA/ANDA: FDA analysis found this product to contain undeclared Tadalafil, an FDA approved drug for the treatment of erectile dysfunction."
http://example.org/fda/8969930053822693516,hasRecallType,Class II
http://example.org/fda/2115013303101624095,hasRecallType,Class II
http://example.org/fda/6204783284194343752,hasRecallReason,Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.
http://example.org/fda/3292556835417591229,hasRecallType,Class I
http://example.org/fda/7151347861633822814,hasRecallReason,"Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this  compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes."
http://example.org/fda/4293490703889273532,hasRecallReason,Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.
http://example.org/fda/2618641840314422808,hasRecallReason,Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
http://example.org/fda/4025920211987324500,hasRecallReason,Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.
http://example.org/fda/5611410291934059589,hasRecallReason,"Stability data does not support expiry: Shelf-life of the impacted lots of BD ChloraPrep"" Clear 1 mL Applicator cannot be substantiated beyond 12-months although labeled with 36-month expiry. Stability studies indicate that the impacted lots, if stored at 30C/75% relative humidity continuously beyond 12 months, may exhibit growth of Aspergillus penicillioides."
http://example.org/fda/8249937228450435289,hasRecallType,Class II
http://example.org/fda/6067345253356013953,hasRecallType,Class III
http://example.org/fda/5512224436346802251,hasRecallType,Class III
http://example.org/fda/8599333852752991943,hasRecallType,Class II
http://example.org/fda/6207215825000821222,hasRecallType,Class II
http://example.org/fda/786799191513177424,hasRecallType,Class II
http://example.org/fda/1475393452617802729,hasRecallType,Class I
http://example.org/fda/8875823208839809553,hasRecallReason,Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
http://example.org/fda/1830341716058408055,hasRecallType,Class II
http://example.org/fda/1096445014040072361,hasRecallType,Class II
http://example.org/fda/349952965678531528,hasRecallType,Class I
http://example.org/fda/6253449738224550884,hasRecallReason,Marketed Without an Approved NDA/ANDA: Product labeled to contain methanol making it an unapproved new drug and contains methanol
http://example.org/fda/1319932464411040860,hasRecallReason,Labeling: Incorrect or missing package insert:  the affected product was packaged with an out-of-date package insert (PI) dated February 2014.
http://example.org/fda/6682384559030334160,hasRecallType,Class II
http://example.org/fda/3788392631936515869,hasRecallType,Class III
http://example.org/fda/6566674024284106046,hasRecallType,Class II
http://example.org/fda/3300757442547937559,hasRecallReason,Microbial contamination
http://example.org/fda/4975216298174330233,hasRecallType,Class II
http://example.org/fda/7579662338017367939,hasRecallType,Class II
http://example.org/fda/8647596829105739892,hasRecallType,Class II
http://example.org/fda/6999866521459425431,hasRecallReason,Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
http://example.org/fda/6135055023904337178,hasRecallType,Class II
http://example.org/fda/2248661098883559703,hasRecallReason,CGMP Deviations:  lots and products of hand sanitizer are being recalled because they were manufactured under the same conditions as the product lot found to contain methanol.
http://example.org/fda/1056908010275815781,hasRecallType,Class II
http://example.org/fda/1978923297206119444,hasRecallReason,Marketed without an approved NDA/ANDA: FDA analysis found products to be tainted with undeclared acetaminophen and sildenafil.
http://example.org/fda/3421464731706914491,hasRecallType,Class II
http://example.org/fda/462513346638658439,hasRecallType,Class II
http://example.org/fda/5417664679205241391,hasRecallType,Class I
http://example.org/fda/1102023555993887318,hasRecallReason,CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
http://example.org/fda/1818728301497308087,hasRecallReason,Presence of Foreign Substance: Belladonna Alkaloids with Phenobarbital Tablets with black specks comprised of degraded organic material on tablets.
http://example.org/fda/8864217284548117099,hasRecallType,Class II
http://example.org/fda/4841523879702864745,hasRecallReason,Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
http://example.org/fda/7235941287482762198,hasRecallReason,Lack of Assurance of Sterility: Sterility of product is not assured.
http://example.org/fda/4494449904627573605,hasRecallReason,Lack of Assurance of Sterility: leaking bags
http://example.org/fda/7943436457673312877,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/51086985408065330,hasRecallType,Class I
http://example.org/fda/7500316074286683933,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/6650164684303736014,hasRecallType,Class II
http://example.org/fda/4589070736164723439,hasRecallType,Class II
http://example.org/fda/5465395455832276156,hasRecallReason,Presence of Foreign Substance: Fragments of wood found when the product was extruded onto a toothbrush.
http://example.org/fda/6804026157138322436,hasRecallReason,"Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance."
http://example.org/fda/6722964123789133386,hasRecallType,Class II
http://example.org/fda/2593560516793204124,hasRecallReason,Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
http://example.org/fda/1911328013464567806,hasRecallReason,"Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug."
http://example.org/fda/1375692992969000735,hasRecallType,Class I
http://example.org/fda/2550754045069763297,hasRecallType,Class II
http://example.org/fda/2987126102226857030,hasRecallType,Class I
http://example.org/fda/3414762844157630710,hasRecallReason,Lack of Assurance of Sterility; medication was sterilized with a recalled filter
http://example.org/fda/6507497283764887805,hasRecallType,Class II
http://example.org/fda/791843767175721890,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/7438527658399186670,hasRecallReason,Subpotent Drug
http://example.org/fda/3238216632870403251,hasRecallReason,Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
http://example.org/fda/2290531880430569568,hasRecallType,Class II
http://example.org/fda/3202925646239676460,hasRecallType,Class II
http://example.org/fda/2447020681124857802,hasRecallType,Class II
http://example.org/fda/7438913159857266858,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/2145718339072524723,hasRecallReason,Lack of assurance of sterility.
http://example.org/fda/3856186205927465774,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/3204354474524368601,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/5506843099378336186,hasRecallType,Class II
http://example.org/fda/3602308182054441867,hasRecallType,Class II
http://example.org/fda/584125729254737492,hasRecallType,Class II
http://example.org/fda/3961392900059836966,hasRecallType,Class III
http://example.org/fda/2824307800266711098,hasRecallReason,Superpotent Drug: The vitamin supplement contains an extremely high level of vitamin D3 (Cholecalciferol).
http://example.org/fda/3308938622265396435,hasRecallReason,cGMP Deviations
http://example.org/fda/4701010981418368259,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/5726868240992351708,hasRecallReason,Presence of Particulate Matter: A complaint was received for the presence of a single strand of hair in one vial.
http://example.org/fda/361511668132543512,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/7341074522472824555,hasRecallType,Class I
http://example.org/fda/3044548868984091977,hasRecallReason,CGMP Deviations: Presence of NDMA impurity detected in product.
http://example.org/fda/5423949778936405437,hasRecallType,Class II
http://example.org/fda/7448981148540570954,hasRecallReason,Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
http://example.org/fda/7132575828604244815,hasRecallReason,Lack of assurance of sterility
http://example.org/fda/1584859512002090817,hasRecallType,Class II
http://example.org/fda/6615831894161208796,hasRecallReason,"Labeling:Label Mixup; guaiFENesin ER, Tablet, 600 mg may be potentially mislabeled as    MISOPROSTOL, Tablet, 200 mcg, NDC 59762500801, Pedigree: AD21965_13, EXP: 5/1/2014;  TACROLIMUS, Capsule, 1 mg, NDC 00781210301, Pedigree: AD56917_7, EXP: 5/21/2014;  LACTOBACILLUS GG, Capsule, NDC 49100036374, Pedigree: AD73627_17, EXP: 5/30/2014;  LACTOBACILLUS GG, Capsule, NDC 49100036374, Pedigree: W003216"
http://example.org/fda/7058022417693223705,hasRecallReason,Labeling mixup: cartons labeled as Daptomycin 350 mg/vial were found to contain vials of Daptomycin 500 mg per vial
http://example.org/fda/480411883193762179,hasRecallReason,The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
http://example.org/fda/113406432808017985,hasRecallType,Class II
http://example.org/fda/3119980038927059285,hasRecallReason,Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
http://example.org/fda/3684473515189917511,hasRecallReason,Failed Dissolution Specifications: failure of dissolution test observed at nine month time point.
http://example.org/fda/2471728450546587796,hasRecallReason,cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
http://example.org/fda/8001244544286080181,hasRecallReason,Microbal Contamination of Non-Sterile Product; FDA analysis found  salmonella contamination
http://example.org/fda/6895855202748201565,hasRecallType,Class II
http://example.org/fda/5943648916631051106,hasRecallType,Class II
http://example.org/fda/5698948276666014329,hasRecallReason,Lack of Assurance of Sterility
http://example.org/fda/4059109629018375519,hasRecallReason,Lack of Assurance of Sterility: product sterility cannot be guaranteed.
http://example.org/fda/4342343230238281583,hasRecallReason,CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
http://example.org/fda/7943436457673312877,hasRecallType,Class II
http://example.org/fda/6780732783606292246,hasRecallType,Class II
http://example.org/fda/7187666116717432308,hasRecallType,Class III
http://example.org/fda/7981858178983219092,hasRecallType,Class II
http://example.org/fda/8592258452443976296,hasRecallType,Class II
http://example.org/fda/3009433468716297314,hasRecallReason,Failed Impurities/Degradation Specificattion
http://example.org/fda/8366006662348132839,hasRecallReason,Lack of Assurance of Sterility: Customer complaints for leaking bags.
http://example.org/fda/3867545482205271616,hasRecallReason,Failed Impurities/Degradation Specifications: Two lots failed specification for unknown impurity at the 24 month stability testing.
http://example.org/fda/7219561343306685358,hasRecallReason,Presence of Foreign Tablets/Capsules.
http://example.org/fda/4359882723004269651,hasRecallType,Class II
http://example.org/fda/526779259811209677,hasRecallType,Class II
http://example.org/fda/2188432617673755329,hasRecallReason,"Labeling: Label Mix-Up; Bottles of Mucinex Fast-Max liquid are correctly labeled on the front of the label, however the back of the bottle where the Drug Facts labeling is, is missing certain Active Ingredients such as acetaminophen, phenylephrine, dextromethorphan, diphenhydramine, and/or guaifenesin. As a result certain safety warnings associated with those ingredients may also be missing."
http://example.org/fda/3791935339253921750,hasRecallReason,Subpotent drug: out of specification results
http://example.org/fda/544218057041155072,hasRecallType,Class II
http://example.org/fda/1939670474922426702,hasRecallType,Class II
http://example.org/fda/2858168771539071938,hasRecallType,Class II
http://example.org/fda/7945090591874624798,hasRecallType,Class II
http://example.org/fda/3261929987364887233,hasRecallReason,Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
http://example.org/fda/4828440713060101927,hasRecallReason,Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center.
http://example.org/fda/8579179636244859683,hasRecallReason,Failed dissolution specifications - low dissolution  results at S3 stage.
http://example.org/fda/5703919552904791628,hasRecallType,Class II
http://example.org/fda/416104188364119155,hasRecallReason,CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.
http://example.org/fda/4788675635256854447,hasRecallReason,Subpotent (Single Ingredient Drug): Low assay at the 6-month test interval.
http://example.org/fda/1329284162774571968,hasRecallReason,"Does Not Meet Monograph: NEW GPC INC. has recalled multiple Over-the-Counter Drug Products due to lack of drug listing, lack of OTC drug labeling requirements and labeled Not Approved for sale in U.S.A.."
http://example.org/fda/2523720119532731862,hasRecallType,Class II
http://example.org/fda/1928468155405670886,hasRecallType,Class II
http://example.org/fda/6548002932721794013,hasRecallType,Class II
http://example.org/fda/2417467768967105799,hasRecallReason,"Labeling:Label Mixup; MELATONIN, Tablet, 1 mg may be potentially mislabeled as    OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: W003711, EXP: 6/26/2014."
http://example.org/fda/4499440969828641411,hasRecallReason,Presence of Foreign Substance: The products are being recalled because they may contain foreign substances.
http://example.org/fda/8864217284548117099,hasRecallReason,The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
http://example.org/fda/8374155116622959289,hasRecallReason,Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
http://example.org/fda/1301868974062475192,hasRecallReason,"Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different products sold individually or as part of multi-unit kits in accordance with Consent Decree of Permanent Injunction ordered by the United States District Court due to misbranding and unapproved new drugs pursuant to the FD&C Act."
http://example.org/fda/2666576358243555232,hasRecallReason,Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
http://example.org/fda/1974181984681623483,hasRecallReason,Lack of sterility assurance
http://example.org/fda/2668989100540572825,hasRecallType,Class II
http://example.org/fda/9191035353714359939,hasRecallType,Class II
http://example.org/fda/1341468551903622727,hasRecallReason,Failed Content Uniformity Specifications
http://example.org/fda/7395120316719566126,hasRecallType,Class II
http://example.org/fda/1977871880864803465,hasRecallReason,Marketed Without An Unapproved NDA/ANDA: All lots were found to be unapproved drugs based on labeling claims.
http://example.org/fda/1776311039531520613,hasRecallReason,Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
http://example.org/fda/7850115000010482902,hasRecallReason,Failed Impurities/Degradation Specification; out of specification results for carbon dioxide
http://example.org/fda/3074593630675410906,hasRecallType,Class III
http://example.org/fda/6597559151259162576,hasRecallReason,Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
http://example.org/fda/6586354867033757226,hasRecallType,Class I
http://example.org/fda/119715835741213627,hasRecallType,Class II
http://example.org/fda/8726605804167565122,hasRecallType,Class II
